Aortic dissection implant

Information

  • Patent Grant
  • 10888414
  • Patent Number
    10,888,414
  • Date Filed
    Thursday, March 19, 2020
    4 years ago
  • Date Issued
    Tuesday, January 12, 2021
    3 years ago
Abstract
A system for treating aortic dissection including an aortic dissection implant comprising an expandable anchoring structure and an elongate tubular structure. The expandable anchoring structure can be configured to apply radial force to the sinuses of the aortic root and/or the sinotubular junction when expanded. The elongate tubular structure can comprise an expandable support frame and one or more layers. The expandable support frame can be configured to extend from the descending aorta to the ascending aorta and curve along with a curvature of the aortic arch when expanded within the aorta. The one or more layers can comprise a first porous layer comprising an atraumatic outer surface positioned over the expandable support frame and a second non-porous layer positioned over a portion of the first porous layer. The second non-porous layer may be configured to be positioned on opposite sides of the aortic dissection and to be inflatable via blood flow to seal against the dissection.
Description
BACKGROUND OF THE INVENTION
Field of the Invention

The present disclosure generally relates to implantable medical devices and, more particularly, to aortic dissection implants, systems for their delivery, and their methods of use.


Description of the Related Art

Acute Aortic Dissections occur when a portion of the aortic intima (the inner most layer of the aorta) ruptures and systemic blood pressure serves to delaminate the intimal layer from the media layer resulting in a false lumen for blood flow that can propagate in multiple directions along the length of the aorta. AAD's impact approximately 7,000 patients in the US annually and are the most common catastrophe of the aorta, carrying very high mortality rates. Dissections that occur in the ascending portion of the aorta make up the majority of cases (63%) and are referred to as Type A, while those occurring in the descending aorta are called Type B. Although Type B AAD's can sometimes be managed medically, Type A dissections typically require immediate surgery. With mortality rates of 1-2% per hour, 25% of patients die within the first 24 to 48 hours, and 80% die within two weeks of diagnosis.



FIGS. 1A-1F illustrates various Types of Acute Aortic Dissections (AADs) that may be referred to herein. Despite the high mortality associated with Type A dissections (FIG. 1A), a need remains for options to treat Type A dissections percutaneously. One option for treating Type A dissections includes a single-piece implant constructed of fabric with built-in reinforcement that resides only in the ascending aorta. However, the shorter length of the implant compromises stability and this option does not address the downstream aspects of the head vessels and the initial portion of the descending aorta. Another option for treatment addresses the downstream portions with a bare-metal implant (no fabric) after the initial dissection in the ascending aorta is treated surgically. In this option, while the reinforcement need is addressed, a complete percutaneous solution is not provided. In some scenarios, attempts to treat a dissection with only a bare metal frame can be attempted, but with the risk that the frame can erode through the tissue or cause the fragile intima layer to dissect further.


Aortic grafts for treating aortic aneurysms may incorporate non-porous graft materials that seek to wall off the aneurysm from the main lumen of the graft and the aorta. Consequently, these grafts can be inappropriate for environments with branch vessels that require fenestration windows and/or other modification. As a result, attempting to apply aortic grafts designed for aneurysms to Type A dissections can be cumbersome or simply impossible. Accordingly, there exists an unmet clinical need for a less invasive, non-surgical solution to treat Type A AADs. There also remains a need for improved treatment for other types of Aortic Dissections, such as shown in FIGS. 1B-1F, as described further herein.


SUMMARY OF THE INVENTION

In some aspects of the disclosure, an aortic dissection system for treating a dissection within an aorta of a patient is disclosed. The aortic dissection system may comprise an aortic dissection implant and a delivery system. The aortic dissection implant may comprise an expandable support structure and at least one layer. The expandable support structure may have a proximal end and a distal end. The at least on layer may be provided over the expandable support structure and comprise an atraumatic outer surface configured to engage an inner wall of the aorta adjacent a false lumen associated with the dissection. The delivery system may be configured to be inserted percutaneously into the patient and advanced into the patient's aorta. The delivery system may comprise an outer sheath configured to receive the aortic dissection implant therein in a compressed configuration.


In some aspects, the at least one layer may comprise a non-porous section configured to extend across at least a portion of the dissection.


In some aspects, the at least one layer may comprise a porous layer provided over the expandable support structure and a non-porous layer provided over the porous layer.


In some aspects, the expandable support structure may be configured to extend from the descending aorta, through the aortic arch and into the ascending aorta. The at least one layer may comprise a porous section configured to permit blood flow from within the expandable support structure, through the porous section, and into the carotid arteries and the subclavian arteries. The at least one layer may comprise a non-porous section comprising an opening to allow blood to flow from within the expandable support structure, through the opening, and into the carotid and the subclavian arteries. The expandable support structure may be pre-formed with a curvature to conform to the aortic arch. The at least one layer may comprise a porous layer configured to substantially cover the expandable support structure from the descending aorta to the sinotubular junction and a non-porous layer partially covering the porous layer and configured to engage a wall of the ascending aorta on opposite sides of a tear of the dissection.


In some aspects, the expandable support structure can be configured to apply radial force to the descending aorta when expanded.


In some aspects, the aortic dissection implant can further comprise an expandable interface structure that may be configured to expand within the aortic root. The expandable interface structure can be configured to extend within the left and right coronary sinuses and distally past the left and right coronary ostia. The expandable interface structure can comprise a wire frame having three lobes. The at least one layer can extend over the expandable support structure and the expandable interface structure. The at least one layer can be configured to extend within the left and right coronary sinuses without blocking blood flow into the left and right coronary arteries.


In some aspects, the at least one layer can comprise a non-porous layer that may be configured to be positioned across at least a portion of the dissection and inflate with blood flow against the inner wall of the aorta adjacent the false lumen. The aortic dissection implant may further comprise at least one valve that can allow blood to enter a space within the non-porous layer but prevent blood from exiting the space.


In some aspects, the delivery system may be configured to sequentially deploy the at least one layer before the expandable support structure.


In some aspects, the system may further comprise one or more temporary longitudinal ribs that can be configured to be removable from the aortic dissection implant. The one or more temporary longitudinal ribs may be configured to maintain a circumferential space between the atraumatic outer surface of the at least one layer and the inner wall of the aorta.


In some aspects, the system can further comprise a temporary external coil that can be configured to surround the aortic dissection implant to maintain a circumferential space between the atraumatic outer surface of the at least one layer and the inner wall of the aorta.


In some aspects, the system can further comprise a suction port along the at least one layer. The suction port may be configured to apply vacuum to a circumferential space between the atraumatic outer surface of the at least one layer and the inner wall of the aorta when a vacuum applicator is applied to the suction port.


In some aspects of the disclosure, an aortic dissection implant for treating a dissection within an aorta of a patient is provided having the features described above and/or as described further below. Any of the aortic dissection implants as described above or as described further herein may comprise an expandable anchoring structure and an elongate tubular structure. The expandable anchoring structure may be configured to be positioned within the aortic root of a patient and apply radial force to one or more of the sinuses of the aortic root and/or the sinotubular junction when expanded. The elongate tubular structure can have a proximal end and a distal end. The proximal end of the elongate tubular structure may be configured to be positioned in the descending aorta. The distal end of the elongate tubular structure can be configured to be positioned in the ascending aorta, the sinotubular junction, or the aortic root. The expandable anchoring structure can be connected to or forms the distal end of the elongate tubular structure. The elongate tubular structure can comprises an expandable support frame, a first porous layer, and a second porous layer. The expandable support frame may have a first length configured to extend from the descending aorta to at least the ascending aorta and curve along with a curvature of the aortic arch when expanded within the aorta. The first porous layer may be positioned over the expandable support frame and may have a second length configured to extend from the descending aorta at least partially through the aortic arch. The first porous layer may comprise an atraumatic outer surface. Expansion of the expandable support frame when positioned within the aorta may expand the first porous layer such that the atraumatic outer surface of the first porous layer presses against an interior surface of the aorta and applies a radial force at least to the descending aorta. The second non-porous layer may be positioned over the expandable support frame and may have a third length that is less than the first length. The second non-porous layer can comprise a first end and a second end that can be configured to be positioned on opposite sides of a tear of the dissection. The second non-porous layer can be inflatable when in use via blood flow through at least the expandable support frame to cause the non-porous layer to expand and seal against at least a portion of the dissection.


The aortic dissection implant of any of the preceding paragraphs or as described further herein can also include one or more of the following features. The second length of the first porous layer can be approximately the same as the first length of the expandable support frame. One or both of the first porous layer and the second non-porous layer can comprise a fabric material. The expandable support frame can comprise a wire, a coiled ribbon, a laser cut structure, or a braid. The atraumatic outer surface of the first porous layer can be configured to engage an interior surface of the aorta within the aortic arch and to allow blood flow from the aortic arch, through the first porous layer, and to the carotid and/or subclavian arteries. The expandable anchoring structure can comprise openings for allowing blood flow to the left and right coronary ostia. The expandable support frame can have a tubular shape when expanded and the expandable anchoring structure can have a cross-sectional dimension larger than a cross-section dimension of the expandable support frame when expanded. The expandable anchoring structure can comprise a trilobe shape. The second non-porous layer can be configured to be positioned over the expandable support frame within the ascending aorta.


In some aspects, the aortic dissection implant of any of the preceding paragraphs or as described further herein can further comprise a third layer between the first layer and the second layer. The third layer can provide for a one-way valve configured to allow blood to enter a space between the first layer and the second layer and prevent blood from exiting the space.


In some aspects of the disclosure, an aortic dissection implant for treating a dissection within an aorta of a patient is provided that comprises a proximal end, a distal end, an expandable support structure, at least one layer, and an expandable interface portion. The proximal end may be configured to be positioned within the descending aorta and the distal end may be configured to be positioned within an aortic root of the patient. The expandable support structure can be configured to extend from the descending aorta to the ascending aorta and curve along with a curvature of the aortic arch when expanded within the aorta. The at least one layer can be provided over the support structure. The at least one layer can comprise a porous section and a non-porous section. The porous section can be configured to curve along with the curvature of the aortic arch and allow blood to flow into the carotid and subclavian arteries of the patient. The non-porous section can be configured to engage a wall of the aorta on opposite sides of a tear in the aorta associated with the dissection. The expandable interface portion at the distal end of the aortic dissection implant can be configured to expand into contact with the aortic root.


The aortic dissection implant of any of the preceding paragraphs or as described further herein can also include one or more of the following features. The expandable support structure may comprise a coiled wire, a coiled ribbon, a laser cut structure, or a braid. The expandable support structure may be formed from one or more of a metal, a polymer, a biological material and a bio-absorbable material. The expandable support structure may comprise a tubular wire frame. the at least one layer may comprise a single layer having variable porosity. The at least one layer may comprise a tubular fabric layer. The at least one layer may comprise a tubular layer that may have radial support features at proximal and distal ends thereof. The expandable interface portion may be contiguous with the at least one layer. The expandable interface portion may be configured to extend within the left and right coronary sinuses and distally past the left and right coronary ostia. The expandable interface portion may comprise openings for allowing blood flow to the left and right coronary ostia. The expandable interface portion may comprise a wire frame having three lobes. The expandable support structure may be a separate structure from the expandable interface portion. The expandable support structure may be connected to the expandable interface portion by the at least one layer. The expandable support structure and the expandable interface portion may be formed from a single wire. The at least one layer may comprise a porous layer that may be configured to substantially cover the expandable support structure from the descending aorta to the sinotubular junction and a non-porous layer that may partially cover the porous layer and may be configured to engage a wall of the aorta on opposite sides of a tear of the dissection. The system may further comprise an expandable portion that may be proximal to the expandable interface portion. The expandable portion may be configured to radially expand against the sinotubular junction.


In some aspects, a method of treating a dissection with an aorta of a patient is disclosed. The method can comprise: delivering an aortic dissection implant in a collapsed configuration percutaneously into a patient to a treatment location within the aorta; and expanding the aortic dissection implant to an expanded configuration within the aorta. After expansion of the aortic dissection implant, a non-porous section of the aortic dissection implant can engage an inner wall of the aorta on opposite sides of a tear of the dissection.


The method of the preceding paragraph or as described further herein can also include one or more of the following features. The aortic dissection implant can comprise a portion that can be expanded within the descending aorta and can apply a radial force at least to the descending aorta. The aortic dissection implant can comprise a portion that can be expanded within the aortic root and can apply a radial force to one or both of the aortic root and the sinotubular junction. After expansion, a porous section of the aortic dissection implant can cover openings to the carotid and subclavian arteries to allow blood flow therethrough. After expansion, a porous section of the aortic dissection implant can cover one or both of the left and right coronary ostia to allow blood flow therethrough. The method can further comprise inflating the non-porous section with blood flow to expand the non-porous layer against the inner wall of the aorta. The method can further comprise reducing a false lumen in the aorta by drawing fluid from the false lumen through natural fenestrations of the aorta.


In some aspects, a dual-layer implant for a blood vessel is disclosed that comprises a first implant layer and a second implant layer. The first implant layer may have an atraumatic outer surface and a first resting diameter. The second implant layer, may be separate from the first implant layer, and may have a second resting diameter that is greater than the first resting diameter. The second implant layer may be configured to be disposed interior to the first implant layer and to expand the first implant layer such that the atraumatic outer surface of the first implant layer presses against a surface of the blood vessel.


The dual-layer implant of the preceding paragraph can also include one or more of the following features. The first implant layer can be a tubular layer having a central lumen that can be configured to receive the second implant layer and to coincide with a true lumen of the blood vessel. The first implant layer can be a fabric layer. The second implant layer can comprise a coil. The coil can be a metal coil. The metal coil can comprise a coil retention feature that can be configured to engage with a coil retention structure of a delivery system and to release from the coil retention structure upon implantation of the second implant layer. The first implant layer and the second implant layer can be bendable to conform to an aortic arch. The first implant layer can include at least a portion that is porous to allow blood flow from the aortic arch, through the first implant layer, to the carotid or subclavian arteries. The dual-layer implant may further comprise an interface structure for interfacing with the native anatomy of the aortic valve cusps. The interface structure may include fenestrations for allowing blood flow to the left and right coronary ostia. The first implant layer may further comprise a non-porous portion and at least one temporary rib. The dual-layer implant may further comprise at least a portion that is radiopaque. The dual-layer implant may further comprise at least a portion that is echogenic. The first implant layer may comprise radial support structures at opposing ends thereof.


In some aspects, a system is disclosed that comprises the dual-layer implant of any one of the preceding paragraphs and a delivery system. The delivery system can be configured to deliver the first implant layer and the second implant layer together into the blood vessel.


In some aspects, a system is disclosed that comprises the dual-layer implant of any one of the preceding paragraphs and a delivery system. The delivery system may be configured to decouple the first implant layer and the second implant layer for asynchronous deployment and release into the blood vessel.


In some aspects, a method of implanting a dual-layer implant is disclosed. The method can comprise: inserting the implant percutaneously into the femoral artery of a patient and advancing the implant into the patient's aorta; retracting an outer sheath to deploy a first implant layer and allow the first implant layer to radially expand to a first resting diameter within the aorta; manipulating a retention structure to deploy a second implant layer, within a lumen of the first implant layer, from the retention structure; further manipulating the retention structure to cause the second implant layer to radially expand to a second resting diameter that is greater than the first resting diameter to cause the first implant layer to radially expand beyond the first resting diameter into contact with the aorta.


The method of the preceding paragraph can also include one or more of the following features. Retracting the outer sheath may deploy deployment arms that may cause the first implant layer to radially expand, and wherein the method further comprising, removing the deployment arms after deployment of the second implant layer. The dual-layer implant may include any of the features of any of the preceding paragraphs. The first implant layer may further comprise a radial support feature at a distal end or a proximal end. The method may further comprise: maintaining, with longitudinal support ribs coupled to the first implant layer, a space between an outer surface of the first implant layer and an interior wall of the aorta; and applying a vacuum to a channel that extends from an inner surface of the first implant layer to the outer surface of the first implant layer to reduce a false lumen in the aorta by drawing fluid from the false lumen through natural fenestrations of the aorta. The method may further comprise removing the longitudinal support ribs.





BRIEF DESCRIPTION OF THE DRAWINGS

The accompanying drawings, which are included to provide further understanding and are incorporated in and constitute a part of this specification, illustrate disclosed embodiments and together with the description serve to explain the principles of the disclosed embodiments.



FIGS. 1A-1B show the common classifications of Aortic Dissections: Stanford Type A and B.



FIGS. 1C-1F show the common classifications of Aortic Dissections DeBakey Type I, II and III.



FIG. 2 is a schematic partial cross-sectional view of an aortic dissection graft system loaded inside a delivery system according to certain aspects of the present disclosure.



FIG. 3 is a schematic perspective view of a graft component of an aortic dissection system according to certain aspects of the present disclosure.



FIG. 4 is a schematic perspective view of a support member of an aortic dissection system according to certain aspects of the present disclosure.



FIG. 5 is another schematic partial cross-sectional view of the aortic dissection system as it is deployed from a delivery system according to certain aspects of the present disclosure.



FIG. 6 is a schematic perspective view of delivery support arms for an aortic dissection system according to certain aspects of the present disclosure.



FIG. 7 is another schematic partial cross-sectional view of an aortic dissection system with delivery support arms as the system is deployed from a delivery system according to certain aspects of the present disclosure.



FIG. 8 is a schematic partial cross-sectional view of an aortic dissection system inside the aortic arch according to certain aspects of the present disclosure.



FIG. 9A is another schematic perspective, partial cross-sectional view of a graft component of an aortic dissection system according to certain aspects of the present disclosure.



FIG. 9B is another schematic partial cross-sectional view of a graft component of an aortic dissection system inside the aortic arch according to certain aspects of the present disclosure.



FIG. 9C is another schematic partial cross-sectional view of an aortic dissection system inside the aortic arch according to certain aspects of the present disclosure.



FIG. 10 is a schematic partial cross-sectional view of the distal end of an aortic dissection implant according to certain aspects of the present disclosure.



FIG. 11 is another schematic partial cross-sectional view of an aortic dissection system deployed inside the aorta according to certain aspects of the present disclosure.



FIG. 12 is schematic cross-sectional view an aortic dissection before deployment of an aortic dissection system in accordance with certain aspects of the present disclosure.



FIGS. 13A-13C are schematic partial cross-sectional views of the aorta during and after deployment of an aortic dissection implant in accordance with certain aspects of the present disclosure.



FIGS. 14A-14D are schematic partial cross-sectional views of the aorta during and after deployment of an aortic dissection implant in accordance with certain aspects of the present disclosure.



FIG. 15A is perspective view of an embodiment of an expandable support structure of an aortic dissection implant according to certain aspects of the present disclosure.



FIG. 15B is a perspective view of an embodiment of the expandable support structure depicted in FIG. 15A with a layer provided within the structure according to certain aspects of the present disclosure.



FIG. 15C is a perspective view of an embodiment of the expandable support structure depicted in FIG. 15A with a layer provided over the structure according to certain aspects of the present disclosure.



FIG. 15D is a perspective view of the distal end an aortic dissection implant according to certain aspects of the present disclosure.



FIG. 16 is a schematic partial cross-sectional view of an aortic dissection implant in the aortic arch according to certain aspects of the present disclosure.



FIG. 17 is a schematic perspective view of another embodiment of an expandable support structure of an aortic dissection implant according to certain aspects of the present disclosure.



FIG. 18 is a schematic perspective view of an embodiment of an expandable support structure of an aortic dissection implant according to certain aspects of the present disclosure.



FIGS. 19A-19B are perspective views of an embodiment of an expandable support structure of an aortic dissection implant according to certain aspects of the present disclosure.





DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

The detailed description set forth below describes various configurations of the subject technology and is not intended to represent the only configurations in which the subject technology may be practiced. The detailed description includes specific details for the purpose of providing a thorough understanding of the subject technology. Accordingly, dimensions may be provided in regard to certain aspects as non-limiting examples. However, it will be apparent to those skilled in the art that the subject technology may be practiced without these specific details. In some instances, well-known structures and components are shown in block diagram form in order to avoid obscuring the concepts of the subject technology.


It is to be understood that the present disclosure includes examples of the subject technology and does not limit the scope of the appended claims. Various aspects of the subject technology will now be disclosed according to particular but non-limiting examples. Various embodiments described in the present disclosure may be carried out in different ways and variations, and in accordance with a desired application or implementation.


In the following detailed description, numerous specific details are set forth to provide a full understanding of the present disclosure. It will be apparent, however, to one ordinarily skilled in the art that embodiments of the present disclosure may be practiced without some of the specific details. In other instances, well-known structures and techniques have not been shown in detail so as not to obscure the disclosure.


Aspects of the subject disclosure are directed to aortic dissection implants, such as dual layer implants, that may be utilized in the treatment of aortic dissections, as well as systems and methods involving the same. In accordance with certain aspects of the subject disclosure, a dual-layer implant is provided that can be used for treatment of Type A Acute Aortic Dissections (AADs), or any other abdominal or thoracic aortic dissection, rupture, or aneurysm. The dual-layer implant can include a first implant layer that forms a soft, atraumatic outer layer to directly contact the intima of the aorta. The dual-layer implant can also include a second implant layer, which can be deployed after or in sequence with the first layer, and that provides reinforcement and direct apposition of the first layer against the intima. Because the first implant layer (e.g., a graft layer) and the second implant layer (e.g., a support structure) in some aspects are not attached together prior to delivery, and can thus be delivered in two separate and/or overlapping steps, the dual-layer implant is sometimes described herein as a dual-layer asynchronous implant. That is, the delivery system for the dual-layer implant, as described in further detail hereinafter, can deploy the two layers together, or can decouple the two layers to allow for asynchronous deployment and release. It will be appreciated that the dual-layer implant as described herein may also be manufactured with the first implant layer provided over the second implant layer, such that the two layers are delivered to a treatment location as a single unit.



FIGS. 2-4 illustrate an aortic dissection implant 102 for use in an aortic dissection system 100 according to certain aspects. The aortic dissection implant 102 can comprise a first implant layer 104, such as a porous and/or non-porous material as described further herein, that may be reinforced with a second implant layer 106, such as a coil, braid, wire frame, Z-stent or any other reinforcement structure as described herein. As used herein, non-porous refers to any material or structure with no openings or openings sufficiently small to prevent blood flow within the ranges of physiological pressures. The aortic dissection system 100 may comprise the aortic dissection implant 102, and a delivery system which may include an outer sheath 108 and/or one or more other delivery components. FIG. 2 illustrates a system 100 including a dual-layer implant 102 packaged for implantation within an outer sheath 108 coupled to a nose cone 114 and mounted to or delivered over a guidewire 116. System 100 is shown in partial cross section in FIG. 2, so that the first implant layer 104 and the second implant layer 106 can be seen. As described in further detail hereinafter, in the delivery configuration shown in FIG. 2, first implant layer 104 and second implant layer 106 are compressed within outer sheath 108 for implantation. Outer sheath 108 can be retracted relative to first implant layer 104 for deployment of first implant layer 104. FIG. 2 also illustrates a retention layer or catheter 110 for second implant layer 106, illustrated in this embodiment as a coil. Retention layer or catheter 110 constrains second implant layer 106 in the compressed configuration of FIG. 2 and is manipulable (e.g., rotatable, retractable or otherwise) for controlled deployment of second implant layer 106. In various examples, dual-layer implant 102 is described herein for treatment of Type A dissections. However, it should be appreciated that dual-layer implant 102 can be applied to Type B dissections and all types of aortic aneurysms as well. It should also be appreciated that in other implementations, implant 102 may comprise more than two layers (e.g. with a secondary graft layer 104 inside of support layer 106 or a secondary support layer inside of support layer 106).


It has been discovered that it is not necessary to “wall-off” the dissected area in the case of AADs, as long as the layers at the source of the dissection can be re-approximated along its length in order to prevent pressure from propagating through the false lumen and to instead direct that pressure through the true lumen. In fact, providing a first implant layer 104 formed from a porous material allows several advantages during deployment (e.g. by not obstructing blood flow), allows for healthier functionality of the aorta, and offers the ability to more easily deal with branch vessels that may be encountered. It is also understood that the aortas in patients with the conditions described herein are very fragile so care must be given in some aspects to make the implant as atraumatic as possible. In some aspects, separating the implant 102 into a soft, atraumatic first layer 104 with a secondary reinforcement layer 106 that is controllably and sequentially deployed asynchronously against the first layer 104 (e.g., after the first layer is in place or prior to the first layer 104 being fully deployed), helps to improve safety. While the native aorta provides its support from the outer-most layer, the implant 102 provides support from the inner-most layer 106 with the softer layer 104 on the outside to appose the soft intima layer of the native aorta.


System 100, initially in the configuration shown in FIG. 2, can be inserted percutaneously into the femoral artery and advanced into the patient's aorta 200. As shown in FIGS. 1A-1F, depending on the desired location of treatment and implantation, the system 100 may be advanced from one of the iliac arteries 202 to the descending aorta 204, and may continue around the aortic arch 206, to the ascending aorta 208, and into the aortic root 210. As used herein, the proximal end of the implant 102 or the system 100 is the end closest to the operator and farthest from the aortic root 210, and the distal end of the implant 102 and the system 100 is the end farthest from the operator and closest to the aortic root 210.


In the delivery configuration of FIG. 2, initial outer layer 104 is retained within outer sheath 108, while the reinforcement layer 106 is retained under torsional tension with a mechanism (e.g., by coil retention structure 110) that is arranged to be unwound or unthreaded to allow the secondary implant layer 106 to deploy. Other mechanisms could be utilized to maintain the reduced diameter of each layer during delivery and allow for controlled diametric expansion upon deployment. For example, second implant layer 106 can be alternatively constrained within an inner sheath that can be retracted linearly for deployment of second implant layer 106. Locking mechanism 112 is provided to maintain connection with the delivery system and allow for repositioning, recapturing and/or removal of implant 102, if needed, prior to full deployment of the implant.



FIG. 3 illustrates a perspective view of one example of first implant layer 104, in accordance with aspects of the disclosure. First implant layer 104 can be formed from fabric, metal, polymer or a biological tissue (as examples). First implant layer 104 is sized such that it is capable of reaching a diameter just slightly beyond that of the native aorta (e.g., a maximum diameter of about 40 to 45 mm) when fully expanded with the reinforcement layer 106 inside. In some aspects, first implant layer 104 can have a resting diameter of 30 mm (or about 30 mm), and may be stretchable or can expand (e.g., by second implant layer 106) to an expanded diameter of 40 mm (or about 40 mm) to 45 mm (or about 45 mm). First implant layer 104 may include one or more porous regions 300 that allows for blood to flow through that region (e.g., if the porous region is deployed across the ostia of a branch vessel). The material of first implant layer 104 may be flexible enough to accommodate the curvature of the aortic arch. In some implementations, the entire length of first implant layer 104 could be porous. In other implementations, the entire length of first implant layer 104 may be non-porous. In still other implementations, the level of porosity may vary throughout the length of first implant layer 104. In still other embodiments where 104 has a given thickness, the porosity of the inner surface may differ from the porosity along the outer surface.


First implant layer 104 may be formed from a fabric that is woven in an open honey-comb shape (as shown in FIG. 3) or in one or more other configurations that afford a wall thickness 304, such that the outer diameter of layer 104 can be disposed against the inside of the aorta, and the inner diameter can be compressed against the outer diameter when the inner reinforcement layer 106 is expanded inside layer 104, to distribute the radial load and avoid putting excessive pressure on the aortic wall.


For example, in other embodiments first implant layer 104 may be formed with an open woven pattern, a laser cut pattern, a braided configuration, or any other form that allows for blood to flow through one or more porous portions 300. In some cases, the porosity of first implant layer 104 varies around the circumference and/or along the length of the first implant layer 104 to achieve targeted levels of porosity against different portions of the patient's anatomy. For example, the porosity of the material itself can vary with position on layer 104, or holes, openings, or other fenestrations can be formed in the material of layer 104.


Additionally, the first implant layer 104 or portions of the first implant layer 104 may be formed of a fabric or polymer that is porous and/or non-porous. The first implant layer 104 could comprise one of or a combination of polyester, nylon, polytetrafluoroethylene (PTFE), or silicone.


In the example of FIG. 3, first implant layer 104 includes radial support features 301 and 302, respectively at its distal and proximal ends. Radial support features 301 and 302 may have a radial compressibility that is less than the radial compressibility of the intervening length of first implant layer 104. Radial support features such as radial support features 301 or 302 can be provided to help secure the position of first implant layer 104 prior to the deployment of second implant layer 106. Radial support features 301 and/or 302, and/or other portions of implant 102 may be radiopaque and/or echogenic so as to allow visualization under fluoroscopy and/or ultrasound intra-procedurally. Radial support features may be provided on an outer surface, an inner surface, or embedded within the implant layer 104. Examples of radial support features include wire frames, coils, braids, and stents have a Z-shape, zig-zag pattern, or more complex geometries, e.g., laser cut from a self-expanding shape memory alloy. Radial support features may have a cylindrical shape, a frustoconical shape or other shapes.


As described in further detail hereinafter (see, e.g., FIGS. 8-10 and the associated description), in some implementations, the distal shape (e.g., including radial support feature 301) of first implant layer 104 (or one or more additional interface structures at the distal end of first implant layer 104) may be arranged to interface with the native anatomy of the aortic valve cusps and left and right coronary ostia, in circumstances in which it is desirable to engage as deep as possible within the aortic root without impacting aortic valve function and without obstructing flow to the coronaries. As used herein, aortic valve cusps are intended to include the sinuses of the aortic root. In some implementations, the distal end of the implant may incorporate a prosthetic aortic heart valve (e.g., coupled to or configured to interface with first implant layer 104).


Second implant layer 106 is a reinforcement layer that provides hoop strength and radial force beyond that of the first implant layer 104, and serves to enhance the apposition of the first implant layer 104 against the intima. Second implant layer 106 may be formed from one or more of a metal (e.g., stainless steel, nitinol, or the like), a polymer, a biological material, a bio-absorbable material, and/or other suitable materials. FIG. 4 shows a perspective view of second implant layer 106, in one implementation. Second implant layer 106 may be a coiled wire forming a wire frame, a coiled ribbon as in the example of FIG. 4, a laser cut structure, a braid or may be formed in another open configuration that can accommodate the curvature of the native aorta. Second implant layer 106 may be completely or partially radiopaque and/or echogenic to enhance visualization intra-procedurally.



FIG. 4 illustrates a perspective view of the second implant layer 106. The second implant layer 106, for example, may be formed as a coiled structure having a pitch of approximately 2 cm, an overall length of between approximately 12-15 cm, a cross-sectional width of approximately 0.5 mm, and a resting diameter of approximately 40 mm to approximately 45 mm. Second implant layer 106 may be radially compressible (e.g., by a compressive force from a portion of the aorta) to a diameter of approximately 30 mm. As illustrated in FIG. 2, second implant layer 106 may also be twisted to a further reduced insertion diameter by coil retention structure 110. In the example of FIG. 4, second implant layer 106 is formed from a coiled ribbon having a cross-sectional height of approximately 5 mm.



FIG. 4 also shows a proximal release feature 400 for second implant layer 106. In the example of FIG. 4, proximal release feature 400 is an opening at the proximal end of second implant layer 106. When twisted into the insertion diameter within coil retention structure 110, proximal release feature 400 may be engaged with a corresponding feature on the interior of coil retention structure 110 (e.g., to prevent rotation of the proximal end of second implant layer within coil retention structure 110 while the proximal end is within coil retention structure 110). As described in further detail in connection with FIG. 5, proximal release feature 400 may disengage from the corresponding feature on the interior of coil retention structure 110 as the proximal end of second implant layer 106 exits coil retention structure 110 to complete the implantation of implant 102. Although second implant layer 106 is depicted in FIG. 4 as a single coil, in other implementations, second implant layer 106 may be implemented as double-coil (e.g., with a parallel pitch or an opposite pitch to form a helix) to provide additional support with opposite pitch to form a helix. In still other implementations, second implant layer 106 can be formed by a coarse braid with multi-fillar construction, a single or multiple piece wire form structure, or a laser cut structure.



FIG. 5 illustrates a perspective and partial cross-sectional view of implant 102 (in partial cross-section for clarity) midway through implantation in the true lumen 504 of a blood vessel 500 having a false lumen 502 associated with a dissection 503. The dissection 503 can have an entry tear and may have one or more re-entry tears. In the configuration of FIG. 5, outer sheath 108 has been partially retracted to allow the first implant layer 104 to expand to its resting diameter within true lumen 504 such that the distal end of first implant layer 104 (and distal radial support feature 301) is distal to the dissection 503 and the proximal end of first implant layer 104 is proximal to dissection 503. In the configuration of FIG. 5, coil retention structure 110 has also been rotated to cause a distal portion of second implant layer 106 to exit an opening 506 at the distal end of coil retention structure 110 to begin to expand to its resting diameter at which second implant layer 106 presses first implant layer 104 against the intima of blood vessel 500. In other embodiments, the retention structure 110 may simply be withdrawn as a sheath in order to expose the second implant layer 106 and allow for its expansion.


From the configuration of FIG. 5, implantation of implant 102 can be completed by further withdrawing outer sheath 108 beyond the proximal end of first implant layer 104 to allow radial support feature 302 to exit the sheath and expand to its resting diameter, and further twisting coil retention structure 110 until second implant layer 106 fully exits through opening 506 (and coil retention feature 400 releases from the corresponding internal feature of coil retention structure 110). Locking features 112 may prevent second implant layer 106 from pulling or sliding proximally on first implant layer 102 during deployment of second implant layer 106.


In this way, deployment of the outer layer 104 is initiated first while maintaining the ability to recapture layer 104 up to any point prior to full release. In implementations in which the material of layer 104 is porous, blood pressure collecting inside the implant is avoided, and the deployment of implant 102 can proceed at a measured pace. Once the distal end of the outer implant layer 104 has been expanded, the user has the option to continue to deploy the outer layer 104 or begin to release a portion of the reinforcement layer 106, to further stabilize the position of the first layer 104. If desired, the majority of outer layer 104 may be released from sheath 108 before the deployment of the reinforcement layer 106 is initiated.


At the beginning of deployment of second implant layer 106, the coil retention structure 110 may be twisted such that a distal portion of second implant layer 106 can emerge from opening 506. After continued rotation of coil retention structure 110, the majority of second implant layer 106 can emerge from coil retention structure 110.


In some implementations, system 100 may include delivery support arms between the initial graft layer 104 and the secondary support layer 106 during delivery. FIG. 6 illustrates a perspective view of example delivery support arms 604, showing four arms. Any number of arms may be provided, such as three or more arms. In order to temporarily expand the graft layer 104 and provide apposition against the intima of the aorta prior to the expansion and secondary support layer 106 to ensure desired location and effect, delivery support arms 604 can be provided in system 100. As shown in FIG. 6, multiple angularly separated delivery support arms 604 may extend from a common base 602 of a delivery support structure 600.



FIG. 7 illustrates system 100, in the delivery state of FIG. 5, in a configuration in which system 100 includes delivery support arms 604. Only two delivery support arms 604 are shown for clarity. As illustrated in FIG. 7, delivery support arms 604 are configured to expand without external assistance as an outer sheath 108 is withdrawn. Base 602 may be coupled to locking mechanism 112 and/or other portions of the delivery system such that delivery support arms 604 move proximally as the delivery sequence progresses (e.g., during deployment of second implant layer 106). Upon full release of both implant layers 104 and 106, outer sheath 108 is advanced interior to the two deployed layers, in order to recapture the delivery support arms for removal. In the example of FIG. 7, delivery support arms 604 extend to the end of first implant layer 104. However, delivery support arms 604 can be provided that are shorter than the distalmost end of second implant layer 106. This arrangement of delivery support arms 604 can help ensure that delivery support arms 604 are not captured between second implant layer 106 and first implant layer 104 when second implant layer 106 is deployed.



FIGS. 5 and 7 illustrate, simply for convenience, deployment of implant 102 in a substantially straight portion of blood vessel 500. However, it should be appreciated that first implant layer 104 and second implant layer 106 as described allow implant 102 to be deployed in curved portions of a blood vessel, and/or in portions of a blood vessel having a varying size.


For example, FIG. 8 illustrates implant 102 deployed within the aortic arch 800. The implant as shown in FIG. 8 may be a sequentially deployed implant as described above, or it may be delivered as a single unit. As shown in FIG. 8, implant 102 comprises an elongate body having a proximal end 806 positioned within the descending aorta 807 and a distal end 808 positioned within the aortic root 809. The implant 102 comprises an expandable reinforcement structure, such as second implant layer 106 described above or any of the other reinforcement structures described herein, that extends from the proximal end 806 in the descending aorta 807 to or near the distal end 808 within the aortic root 809. An interface portion 802 is provided at the distal end 808 of the implant 102, which may be expandable within the aortic root 809 to anchor and secure the implant 102. The interface portion 802 may comprise an expandable wire frame and may be part of or separate from the reinforcement structure extending through the ascending aorta and descending aorta. Provided over the reinforcement structure are one more outer layers, such as implant layer 104 described above or any of the other layers described herein for covering the reinforcement structure and/or for contacting an inner wall of the aorta. For example, a porous implant layer 104 may extend from the proximal end 806 to the distal end 808 over the entire or substantially the entire reinforcement structure, optionally including the interface portion 802.


As shown in FIG. 8 (in partial cross-section for clarity), both first implant layer 104 and second implant layer 106 are curved along with the curvature of aortic arch 800, and fenestrations 801 in first implant layer 104 allow blood flow through first implant layer 104 into the carotid and subclavian arteries 811. In some embodiments, the first implant layer 104 has a porous section 810 configured to be located within the aortic arch 800 to allow blood to flow into the carotid and subclavian arteries 811. The implant 102 may further comprise, as part of the first implant layer 104 or as an additional layer, a non-porous section 118 located distal to the porous section 810 of the first implant layer 104. The non-porous section 118 can be configured to engage a wall of the aorta adjacent to the false lumen 502 and over the entry tear of dissection 503. In some embodiments, the first implant layer 104 is entirely porous. In some embodiments, the non-porous section 118 is a separate layer provided over the first implant layer 104 that is entirely non-porous.



FIG. 8 also shows how an interface portion 802 (e.g., contiguous with or coupled to first implant layer 104 and/or the second implant layer 106) can be provided at the distal end of implant 102. As shown, interface portion 802 is configured to conform to the native anatomy of the aortic valve cusps, e.g., to the sinuses of the aortic root, and includes fenestrations 804 for the left and right coronary ostia. As illustrated, the interface portion 802 may comprise an expandable wire frame having three lobes, each lobe configured to be positioned in and expandable to engage with one of the sinuses of the aortic root. Any or all of the lobes may be partially or entirely covered with a porous material or non-porous material, such as porous material of the first implant layer 104 or non-porous material of the additional implant layer 118. As illustrated, the lobes in the left coronary and right coronary aortic sinuses may extend distally beyond the left and right coronary arteries 813, 815, respectively. When covered with porous material, blood will be allowed to flow through the porous material covering these lobes into the left and right coronary arteries.



FIG. 9A illustrates a perspective view of another aspect of an implant 102 comprising a first implant layer 104 in a dual-layer honeycomb fabric implementation with an elongate opening 900 (e.g., for alignment with the carotid and/or subclavian arteries). FIG. 9B illustrates a partial cross-sectional view of first implant layer 104 deployed within the aortic arch. As shown in FIG. 9B, the elongate opening 900 may align with the carotid and subclavian arteries such that blood may flow through the elongate opening 900 and into the arteries. The layer 104 in this embodiment may be non-porous to prevent blood from flowing into the dissection 503. FIG. 9B illustrates the implant 102 without a reinforcement structure or second implant layer 106. FIG. 9C illustrates a partial cross-sectional view of an implant 102 comprising a first implant layer 104 like in FIG. 9A with second implant layer 106 provided within the first implant layer 104. An interface portion 802 as described above may anchor the first implant layer 104 and/or the second implant layer 106 to the aortic root.



FIG. 10 illustrates an edge shape for interface portion 802 that can expand to conform to the native anatomy. The interface portion 802 may comprise a first expandable component 814. For example, the interface portion 802 can comprise a first expandable component 814 that can be configured to be positioned within the aortic root of a patient and apply radial force to one or more of the sinuses of the aortic root when expanded. The first component 814 can comprise multiple lobes, such as three lobes to form a trilobe anchoring structure, wherein the lobes are configured to engage with each of the sinuses of the aortic root and apply radial force to secure the first component 814 to the aortic root. Additionally, as shown FIG. 10, the interface portion 802 can comprise a second expandable component 812 proximal to the first expandable component 814 that can be configured to be positioned within the sinotubular junction and apply radial force to this junction when expanded. In different embodiments, the interface portion 802 can comprise either the first expandable component 814 or the second expandable component 812.


Additionally, the shape of the first implant layer 104 at the interface portion 802 may be shaped such that the first implant layer 104 does not impede blood flow through the coronary ostia. As illustrated, the first implant layer 104 may extend distally from the ascending aorta into the left and right aortic sinuses to cover only part of the interface portion 802 in the left and right aortic sinuses, but may terminate proximal to the left and right coronary arteries to allow blood to flow therethrough. The first implant layer 104 may also extend distally from the ascending aorta into the non-coronary aortic sinuses and cover part or all of the interface portion 802 in the non-coronary aortic sinuses.



FIG. 11 illustrates one example of implant 102 during deployment in a portion of blood vessel 500 with a varying diameter, showing how second implant layer 106 is variably compressible (e.g., responsive to the radial strength of the walls of blood vessel 500) to conform first implant layer 104 along the walls of the blood vessel.



FIGS. 12-14D illustrate how, in some implementations, an implant 1302, 1402 can include features that allow further obliteration of a false lumen 1201. FIG. 12 illustrates a cross-sectional view of a blood vessel having a true lumen 1207, a false lumen 1201 associated with a dissection 1203, and natural fenestrations 1205 adjacent to the false lumen 1201. In the examples of FIGS. 13A-13C, a first implant layer 1304 is provided over a second implant layer 1306 with a suction port 1310 that provides a channel to which vacuum can be applied via a vacuum applicator 1312. The first implant layer 1304 can comprise features as described above for other first implant layers or any of the other first implant layers described herein. Moreover, the second implant layer 1306 may include features as described above for other second implant layers or any other reinforcement structures described herein. In this example, one or more longitudinal ribs 1308 can be provided to maintain a circumferential space between the outer surface of layer 1304 and the interior wall of the native aorta. The one or more longitudinal ribs 1308 may extend axially along a length of the implant 1302, and may have a stiffness greater than that of the second implant layer 1306. The one or more longitudinal ribs may have a curvature or be bowed, thereby preventing the implant layer 1306 from fully expanding. When the implant 1302 is sealed around the dissection 1203, a vacuum may be applied to channel 1310. As shown in FIG. 13B, this causes the surrounding false lumen 1201 to be reduced by drawing fluid from the false lumen 1201 through the entry tear 1203 and the natural fenestrations 1205 of the native aorta. As shown in FIG. 13C, support ribs 1308 can then be removed to allow for apposition of the implant surface to the native aorta against the media and adventitia layers, thereby minimizing the false lumen 1201 and maximizing the cross-section of the true lumen 1207.


In some embodiments, implant 1302 can include a solid, non-porous graft portion that can be used, for example, for Type B dissections that are in the descending aorta. In these examples, implant 1302 maintains a suction lumen 1310 that runs from the inner diameter of the graft to communicate with an area on the outer diameter of the graft adjacent to the false lumen 1201. Using temporary longitudinal support ribs 1308 to maintain the space (see, e.g., FIGS. 13A-13B), a vacuum is drawn in space between the implant 1302 and the false lumen 1201 to attempt to empty out the false lumen 1201 through the natural porosity 1205 of the native aorta. Once the false lumen 1201 is drawn down, then the support ribs 1308 can be removed (see, e.g., FIG. 13C) and the implanted graft 1302 can radially expand to its full diameter and further reduce the false lumen 1201 which has been emptied of pooled blood as indicated with reduced false lumen 1201 in FIG. 13C.


In the examples of FIGS. 14A-14D, a first implant layer 1404 is provided over a second implant layer 1406 with a suction port 1410 that provides a channel to which vacuum can be applied via a vacuum applicator 1412. In this example, an external coil 1414 can be wrapped around the outside of a central portion of the implant 1402 and passed through the suction portion 1410 and vacuum applicator 1412. The external coil 1414 is provided to maintain a circumferential space between the outer surface of first implant layer 1404 and the interior wall of the native aorta, so that when a vacuum is applied to port 1410, the surrounding false lumen 1201 would be reduced by drawing fluid from the false lumen 1201 through the entry tear 1203 and the natural fenestrations 1205 of the native aorta. As shown in FIGS. 14C-14D, the external coil 1414 can then be removed to allow for apposition of the implant surface to the native aorta against the media and adventitia layers, thereby minimizing the false lumen 1201 and maximizing the cross-section of the true lumen 1207.


In some embodiments, implant 1402 can include a solid, non-porous graft portion that can be used, for example, for Type B dissections that are in the descending aorta. In these examples, implant 1402 maintains a suction lumen 1410 that runs from the inner diameter of the graft to communicate with an area on the outer diameter of the graft adjacent to the false lumen 1201. Using the temporary external coil 1414 to maintain the space (see, e.g., FIGS. 14A-14B), a vacuum is drawn in space between the implant 1402 and the false lumen 1201 to attempt to empty out the false lumen 1201 through the natural porosity 1205 of the native aorta. Once the false lumen 1201 is drawn down, then the external coil 1414 can be removed (see, e.g., FIGS. 14C-14D) and the implanted graft 1402 can radially expand to its full diameter and further reduce the false lumen 1201 which has been emptied of pooled blood as indicated with reduced false lumen 1201 in FIG. 14D.



FIGS. 12-14D illustrate, simply for convenience, deployment of implant 1302, 1402 in a substantially straight portion of blood vessel. However, it should be appreciated that first implant layer 1304, 1404 and second implant layer 1306, 1406 as described allow implant 102 to be deployed in curved portions of a blood vessel, and/or in portions of a blood vessel having a varying size.


Generally, porous versions of implant 102 may be useful for any Type A (I or II) dissections (see, e.g., FIG. 1A) that require extending through the head vessels, and can also be applied to some Type B incidents (see, e.g., FIG. 1B). The non-porous graft option 1302, 1402 of FIGS. 13A-14D may be more applicable to certain Type B configurations. Variable porosity of layer 104, 1304, 1404 (e.g., one section solid, another segment porous, or different degrees of porosity) can be used to offer solutions for different dissection or aneurysm configurations.



FIGS. 15A-15C depict another embodiment of an aortic dissection implant 1700. FIG. 15A depicts an implant layer such as described above that comprises a generally tubular, expandable support structure that extends from a proximal end 1702 to a distal end 1704. The embodiment of the expandable support structure depicted in FIG. 15A shows a wire frame or wire coil 1713 with a zig-zag or Z-shaped pattern along a cylindrical portion 1710 of the coil 1713. Additionally, the expandable support structure can comprise other patterns that are suited for being used to treat an aortic dissection. Furthermore, the expandable support structure may be a laser cut structure, a braid or may be formed in another open configuration that can accommodate the curvature of the native aorta. The expandable support structure may also be completely or partially radiopaque and/or echogenic to enhance visualization intra-procedurally. The cylindrical portion 1710 of the coil 1713 can be configured to extend from the descending aorta to the ascending aorta and curve along with a curvature of the aortic arch when expanded within the aorta.


At the distal end 1704, the implant 1700 may comprise an expandable anchoring structure 1715 such as the interface portion described above. The expandable anchoring structure 1715 may have an enlarged cross-sectional diameter when expanded as compared to the cylindrical portion 1710. The expandable anchoring structure 1715 can comprise one or more components. For example, the expandable anchoring structure 1715 can comprise a first expandable component 1706, such as the first expandable component described above, that can be configured to be positioned within the aortic root of a patient and apply radial force to the sinuses of the aortic root when expanded. The first component 1706 can comprise multiple lobes, such as three lobes to form a trilobe anchoring structure, wherein the lobes are configured to engage with each of the sinuses of the aortic root and apply radial force to secure the first component 1706 to the aortic root. Additionally, as shown FIG. 15A, the expandable anchoring structure 1715 can comprise a second expandable component 1708 proximal to the first expandable component 1706, such as the second expandable component described above, that can be configured to be positioned within the sinotubular junction and apply radial force to this junction when expanded. The second expandable component 1718 may have a frustoconical shape in some embodiments, with a smaller diameter proximal end and a larger diameter distal end, to provide a transition between the cylindrical portion 1710 and the enlarged expandable component 1706. In different embodiments, the expandable anchoring structure 1715 can comprise either the first expandable component 1706 or the second expandable component 1708.


In some aspects, the wire frame 1713 may be a continuous wire that forms the first expandable component 1706, the second expandable component 1708 and the cylindrical portion 1710. In other aspects, the first expandable component 1706, the second expandable component 1708 and the cylindrical portion 1710 may be formed from separate wire frames. The wire frame 1713 may be formed from one or more of a metal (e.g., stainless steel, nitinol, or the like), a polymer, a biological material, a bio-absorbable material, and/or other suitable materials. In some aspects, the wire frame 1713 may have an overall length of between approximately 12-15 cm, a cross-sectional width or diameter of the wire of approximately 0.5 mm, and a resting diameter in the cylindrical portion 1710 of approximately 40 mm to approximately 45 mm. The wire frame 1713 may be radially compressible to a diameter of approximately 10 mm or less. The expandable anchoring structure 1715 may have a diameter of approximately 45 to 55 when expanded.



FIGS. 15B-15C illustrate embodiments of the aortic dissection implant that comprises the wire frame 1713 with a layer 1714 provided either within (FIG. 15B) or over (FIG. 15C) the wire frame 1713. The layer 1714 can extend from the proximal end 1702 of the wire frame 1713 to the distal end 1704 of the wire frame 1713. In some embodiments, the layer 1714 may cover the second expandable component 1708 of the expandable anchoring structure 1715 and part of the first expandable component 1706 of the expandable anchoring structure 1715. This configuration allows for the coronary ostia to remain uncovered after implantation of the aortic dissection implant, which allows blood to flow freely through the ostia. In other embodiments, the layer 1714 may extend to the distal end of the expandable anchoring structure 1715.


In some aspects, the layer 1714 can be formed from fabric, metal, polymer or a biological tissue. The layer 1714 is sized such that it is capable of reaching a diameter just slightly beyond that of the native aorta (e.g., a maximum diameter of about 40 mm to about 45 mm) when fully expanded with the wire frame 1713 inside. In other implementations, the layer 1714 can have a resting diameter of 35 mm and an expanded diameter of 40 mm. The material of the layer 1714 may be flexible enough to accommodate the curvature of the aortic arch. In some implementations, the entire length of layer 1714 could be porous. In other implementations, the entire length of layer 1714 may be non-porous. In still other implementations, the level of porosity may vary throughout the length of layer 1714. For example, the portion of the layer 1714 along a distal portion of the cylindrical portion 1710 may be non-porous and the portion of the layer 1714 along a proximal portion of the cylindrical portion 1710 may be porous (e.g., as shown in FIG. 8). In this embodiment, the porous section of the layer 1714 can be configured to curve along the curvature of the aortic arch and allow blood to flow into the carotid and subclavian arteries of the patient. The non-porous section of this embodiment can be configured to engage with the wall of the aorta adjacent a false lumen associated with the dissection. The wire frame 1713 provides hoop strength and radial force beyond that of the layer 1714, and serves to enhance the apposition of the layer 1714 against the intima.


In some embodiments, the wire frame 1713 shown in FIGS. 15A-15D can be created from a single piece of wire. FIG. 15D depicts the distal end 1704 of the embodiment of the aortic dissection implant shown in FIGS. 15A-15B. The back portion of the second expandable component 1708 and the frustoconical portion of the layer 1714 covering the second expandable component are not shown in FIG. 15D for clarity. A distal portion 1720 of the single wire can be located at the distal end 1704 of the wire frame 1713. The single wire can be bent to form the trilobe structure of the first component 1706 of the expandable anchoring mechanism. At a first transition portion 1718 of the single wire, the wire can be bent in such a way to form the second component 1708 of the expandable anchoring structure. As illustrated, the second component 1708 may be made with the wire 1713 forming a sine wave around a circumference of the implant. At a second transition portion 1716 of the single wire, the wire can be bent to begin forming the Z-shaped or zig-zag pattern of the cylindrical portion 1710 of the wire frame 1713 following generally spiral or helical shaped path. After the wire frame 1713 is formed, the distal portion 1720 is crimped or welded to the first transition portion 1718. Additionally, at the proximal end 1702 of the coil 1700, as shown in FIG. 15B, a proximal end of the single wire can be crimped or welded to the portion of the coil 1700 directly distal to the proximal end of the single wire. In other embodiments, the coil 1700 can comprise multiple wires welded together. In other embodiments, a single wire may extend from the distal (or proximal end) of the implant, to the other end, and back.



FIG. 16 illustrates a partial cross-sectional view of another embodiment of an implant 1802 deployed within the aortic arch and extending between the descending aorta, through the ascending aorta, and into the aortic root. In this embodiment, the implant 1802 may comprise a first layer 1814, a second layer 1822, and an expandable support structure 1800. The expandable support structure 1800 may be similar to the wire frame 1713 depicted in FIGS. 15A-15D and described in the foregoing paragraphs, or it may be similar to any of the earlier described embodiments of reinforcement structures. The expandable support structure 1800 may comprise a cylindrical coil or wire frame that can comprise a sinusoidal wave pattern, Z-shape or zig-zag pattern. The expandable support structure 1800 can be configured to extend from the descending aorta to the ascending aorta and curve along with the curvature of the aortic arch when expanded within the aorta. In some aspects, the distal end of the expandable support structure may comprise an expandable anchoring structure 1815 as described above. In some embodiments, the expandable anchoring structure 1815 can comprise an expandable trilobe structure 1806 that can be configured to be positioned within the aortic root of a patient and apply radial force to the sinuses of the aortic root. In some embodiments, the expandable anchoring structure 1815 may comprise a sinusoidal wave structure 1812 that may be configured to be positioned within the sinotubular junction and apply radial force to the sinotubular junction. In the embodiment shown in FIG. 16, the expandable anchoring structure 1815 comprises both the expandable trilobe structure 1806 and the sinusoidal wave structure 1812.


In some aspects, the implant 1802, and particularly the expandable support structure 1800, may be configured to expand within at least the descending aorta to press against and apply radial force to the inner wall of the descending aorta. In such embodiments, a diameter of the expandable support structure in at least a proximal portion thereof is larger than an inner diameter of the descending aorta. The implant 1802 may also be configured such that a distal portion of the implant, and particularly a distal portion of the expandable structure, is smaller than an inner diameter of the ascending aorta.


The first layer 1814 may be provided over the expandable support structure 1800 and may be configured to extend from the proximal end of the expandable support structure 1800 at least to the sinusoidal wave structure 1812. In some aspects, the first layer 1814 can be formed from fabric, metal, polymer or a biological tissue, and may be made of any of the materials described above for layer 104. The first layer 1814 may be sized such that it is capable of reaching a diameter just slightly below that of the native ascending aorta (e.g., a maximum diameter of about 35 mm) when fully expanded with the expandable support structure 1800 inside. In other implementations, the first layer 1814 can have resting diameter of 35 mm and an expanded diameter of 40 mm such that it could be expanded by the support structure 1800 to contact the inner most wall of the native descending aorta. The material of the first layer 1814 may be flexible enough to accommodate the curvature of the aortic arch. In some implementations, the entire length of first layer 1814 may be non-porous or the level of porosity may vary throughout the length of first layer 1814. In the embodiment of the aortic dissection implant shown in FIG. 16, the entire length of first layer 1814 is porous. The porosity of the first layer 1814 could be configured to allow blood to flow into the carotid and subclavian arteries of the patient. The expandable support structure 1800 provides hoop strength and radial force beyond that of the layer 1814, and serves to enhance the apposition of the layer 1814 against the intima.


The second layer 1822 may be provided over the first layer 1814 and may be configured to contact the site of the aortic dissection and the aortic wall adjacent to the false lumen. In some aspects, the length of the second layer 1822 may be less than the length of the first layer 1814. The second layer can extend along one of the lobes of the trilobe structure 1806, e.g., the lobe positioned in the non-coronary aortic sinus, and the other two lobes remain uncovered so that blood may flow through the coronary ostia. The second layer 1822 can be formed from fabric, metal, polymer or a biological tissue, including any of the materials that may be utilized for the first layer 1814. In the embodiment of the second layer 1822 shown in FIG. 16, the entire length of the second layer 1822 is non-porous.


In some embodiments, both ends of the second layer 1822 may be sealed to the first layer 1814 and the second layer 1822 may be configured to expand like a balloon when blood flows through the implant, as indicated by the arrows in FIG. 16. In particular, blood may flow through the first layer 1814 and expand the second layer 1822 such that there is space between the first layer 1814 and the second layer 1822. The expanded diameter of the second layer 1822 may be larger than the diameter of the first layer 1814 (e.g., 45 mm for 1822 versus 35 mm for 1814). The second layer 1822 may remain inflated against the aortic wall such that the second layer 1822 applies radial force to the aortic dissection site to seal the entry tear prevent blood from flowing into the false lumen. In some instances, an additional (third) layer that is non-porous may be disposed between the first porous layer 1814 and the second non-porous layer 1822 such that the third layer provides for a one-way valve that allows blood to enter the space between layers 1814 and 1822 but prevents it from exiting. This could be accomplished by laser cutting or otherwise creating gills, slots or flaps in the third layer that can open into the space during systole when blood pressure is highest but close against the first porous layer when that pressure is reduced during diastole preventing the blood from exiting.


In another embodiment, the aortic dissection implant can comprise a single layer that extends from the distal end to the proximal end of the expandable support structure. The single layer can comprise an inflatable non-porous section and a porous section proximal to the inflatable non-porous section. The inflatable non-porous section may be similar to the second layer 1822 and the porous section may be similar to the first layer 1814 shown in FIG. 16 and described in the foregoing paragraphs.



FIG. 17 illustrates another embodiment of an expandable support structure 1900. The expandable support structure 1900 can comprise a braided configuration, as illustrated in FIG. 19, and be configured to extend from the descending aorta to the ascending aorta and curve along with the curvature of the aortic arch when expanded within the aorta. In some aspects, the expandable support structure 1900 may be formed from one or more of a metal (e.g., stainless steel, nitinol, or the like), a polymer, a biological material, a bio-absorbable material, and/or other suitable materials. In other aspects, the expandable support structure 1900 may have length of approximately 15 cm and a diameter of approximately 40 mm. This embodiment of an expandable support structure 1900 may be used in the different embodiments described in the foregoing paragraphs.



FIG. 18 depicts another embodiment of a first implant layer 2000. The first implant layer 2000 can comprise a layer 2008, a distal expandable support structure 2002, a proximal expandable support structure 2004, and an axial support structure 2006. In some aspects, the layer 2008 may be non-porous and can be formed from fabric, metal, polymer or a biological tissue. The layer 2008 can be cylindrical in shape and be configured to be flexible such that the layer 2008 can conform to the shape of the ascending aorta. In some embodiments, length of the layer 2008 may be adjusted at the time of the procedure prior to inserting the first implant layer 2000 into the patient. In some aspects, the layer 2008 can have a length of approximately 4 cm to 8 cm and a diameter of approximately 30 mm to 40 mm. The distal portion of the layer 2008 may form a frustoconical shape in some embodiments, with a smaller diameter of approximately 30 mm at a proximal end and a larger diameter of approximately 40 mm at a distal end.


The distal and proximal expandable support structures 2002, 2004 may be provided over or within the layer 2008 and apply radial force to layer 2008 against the intima of the ascending aorta when expanded within the ascending aorta. The distal expandable support structure 2002 may comprise a zig-zag pattern. The proximal expandable structure 2004 may comprise a sine wave pattern, a sine wave pattern and/or a trilobe pattern. In some aspects, the distal and proximal expandable support structures 2002, 2004 may be formed from one or more of a metal (e.g., stainless steel, nitinol, or the like), a polymer, a biological material, a bio-absorbable material, and/or other suitable materials. The diameter of the distal expandable support structure 2002 may be between 35 mm and 40 mm. The diameter of the proximal expandable support structure 2004 may be approximately 30 mm.


The first implant layer 2000 may also comprise an axial support structure 2006. The axial support structure 2006 may be provided over, within, or interwoven into the layer 2008. The axial support structure 2006 may extend between a distal end and a proximal end of the layer 2008 and may provide reinforcement to the first implant layer 2000.


The first implant layer can be deployed within a patient's aorta to provide force against the site of an aortic dissection. Following the placement of first implant layer 2000, a second long-term support structure (e.g., the expandable support structure depicted in FIG. 15A or 17) may be deployed inside of the first implant layer along the aortic arch and across the carotid and subclavian arteries to the descending aorta. Prior to deployment, the length and/or diameter of the first expandable support structure of FIG. 18 can be sized separately from the later deployed expandable support structure.



FIGS. 19A and 19B illustrate another embodiment of the expandable support structure. This embodiment of the expandable support structure 2100 may have a braided configuration, similar to the embodiment described in FIG. 17, and be configured to extend from the descending aorta to the ascending aorta and curve along with the curvature of the aortic arch when expanded within the aorta. In some aspects, the expandable support structure 2100 may be formed from one or more of a metal (e.g., stainless steel, nitinol, or the like), a polymer, a biological material, a bio-absorbable material, and/or other suitable materials. In other aspects, the expandable support structure 2100 may have length of approximately 15 cm and a diameter of approximately 40 mm. This embodiment of an expandable support structure 2100 may be used in the different embodiments described in the foregoing paragraphs.



FIG. 19A depicts the expandable support structure 2100 in a curved orientation and FIG. 19B depicts the expandable structure 2100 in a straight orientation. The expandable support structure 2100 may comprise an anchoring mechanism 2104 at the distal end and a cylindrical portion 2102 proximal to the anchoring mechanism 2104. The anchoring mechanism 2104 may comprise three lobes that can be configured to be positioned within the aortic root of a patient and apply radial force to the sinuses of the aortic root. The cylindrical portion 2102 may be configured to extend from the descending aorta to the ascending aorta and curve along with the curvature of the aortic arch when expanded within the aorta.


In some embodiments, the aortic dissection implant, as described in the foregoing paragraphs, can be preformed during manufacturing. For example, the implant can be preformed to include a bend with a radius of curvature of approximately 35 mm and an angle of curvature of 150 degrees to 180 degrees. This bend can be configured to be positioned along the curvature of the aortic arch. In some embodiments that include trilobe anchoring structures, the preformed shape may be aligned with respect to the non-coronary aortic sinus (e.g. the major bend of the aortic arch could be approximately 90 degrees from the non-coronary aortic sinus). In other embodiments, specific features like the window 900 in FIG. 9A-C could also be aligned with the pre-formed curvature of the implant and/or specific trilobe features as noted above.


In some embodiments, the aortic dissection implant, as described in the foregoing paragraphs, may have variable dimensions to assist in securing and anchoring of the implant. For example, the implant in an expanded configuration may have a relatively larger diameter at its distal end (e.g., about 35 mm or more, to anchor for example in the aortic root and/or the sinotubular junction), a relatively smaller diameter in an middle portion (e.g., about 30 mm or less, to position for example in the ascending aorta without exerting additional radial force on the fragile aortic wall where a dissection has occurred), and a relatively larger diameter at its proximal end (e.g., about 35 mm or more, to anchor for example in the descending aorta). In other embodiments it may have a relatively smaller diameter in its proximal region (e.g., 30 mm or less) to conform to a smaller descending aorta diameter and a relatively larger diameter in the middle portion if the ascending aorta diameter is much larger and dilated (e.g., 40 mm).


It is understood that any specific order or hierarchy of blocks in the processes disclosed is an illustration of example approaches. Based upon implementation preferences, it is understood that the specific order or hierarchy of blocks in the processes may be rearranged, or that not all illustrated blocks be performed. Any of the blocks may be performed simultaneously. In one or more embodiments, multitasking and parallel processing may be advantageous. Moreover, the separation of various system components in the embodiments described above should not be understood as requiring such separation in all embodiments, and it should be understood that the described program components and systems can generally be integrated together in a single software product or packaged into multiple software products.


The subject technology is illustrated, for example, according to various aspects described above. The present disclosure is provided to enable any person skilled in the art to practice the various aspects described herein. The disclosure provides various examples of the subject technology, and the subject technology is not limited to these examples. Various modifications to these aspects will be readily apparent to those skilled in the art, and the generic principles defined herein may be applied to other aspects.


A reference to an element in the singular is not intended to mean “one and only one” unless specifically so stated, but rather “one or more.” Unless specifically stated otherwise, the term “some” refers to one or more. Pronouns in the masculine (e.g., his) include the feminine and neuter gender (e.g., her and its) and vice versa. Headings and subheadings, if any, are used for convenience only and do not limit the invention.


The word “exemplary” is used herein to mean “serving as an example or illustration.” Any aspect or design described herein as “exemplary” is not necessarily to be construed as preferred or advantageous over other aspects or designs. In one aspect, various alternative configurations and operations described herein may be considered to be at least equivalent.


As used herein, the phrase “at least one of” preceding a series of items, with the term “or” to separate any of the items, modifies the list as a whole, rather than each item of the list. The phrase “at least one of” does not require selection of at least one item; rather, the phrase allows a meaning that includes at least one of any one of the items, and/or at least one of any combination of the items, and/or at least one of each of the items. By way of example, the phrase “at least one of A, B, or C” may refer to: only A, only B, or only C; or any combination of A, B, and C.


A phrase such as an “aspect” does not imply that such aspect is essential to the subject technology or that such aspect applies to all configurations of the subject technology. A disclosure relating to an aspect may apply to all configurations, or one or more configurations. An aspect may provide one or more examples. A phrase such as an aspect may refer to one or more aspects and vice versa. A phrase such as an “embodiment” does not imply that such embodiment is essential to the subject technology or that such embodiment applies to all configurations of the subject technology. A disclosure relating to an embodiment may apply to all embodiments, or one or more embodiments. An embodiment may provide one or more examples. A phrase such an embodiment may refer to one or more embodiments and vice versa. A phrase such as a “configuration” does not imply that such configuration is essential to the subject technology or that such configuration applies to all configurations of the subject technology. A disclosure relating to a configuration may apply to all configurations, or one or more configurations. A configuration may provide one or more examples. A phrase such a configuration may refer to one or more configurations and vice versa.


In one aspect, unless otherwise stated, all measurements, values, ratings, positions, magnitudes, sizes, and other specifications that are set forth in this specification, including in the claims that follow, are approximate, not exact. In one aspect, they are intended to have a reasonable range that is consistent with the functions to which they relate and with what is customary in the art to which they pertain.


It is understood that some or all steps, operations, or processes may be performed automatically, without the intervention of a user. Method claims may be provided to present elements of the various steps, operations or processes in a sample order, and are not meant to be limited to the specific order or hierarchy presented.


All structural and functional equivalents to the elements of the various aspects described throughout this disclosure that are known or later come to be known to those of ordinary skill in the art are expressly incorporated herein by reference and are intended to be encompassed by the appended claims. Moreover, nothing disclosed herein is intended to be dedicated to the public regardless of whether such disclosure is explicitly recited in the claims. No claims element is to be construed under the provisions of 35 U.S.C. § 112 (f) unless the element is expressly recited using the phrase “means for” or, in the case of a method, the element is recited using the phrase “step for.” Furthermore, to the extent that the term “include,” “have,” or the like is used, such term is intended to be inclusive in a manner similar to the term “comprise” as “comprise” is interpreted when employed as a transitional word in a claim.


The Title, Background, Brief Description of the Drawings, and Claims of the disclosure are hereby incorporated into the disclosure and are provided as illustrative examples of the disclosure, not as restrictive descriptions. It is submitted with the understanding that they will not be used to limit the scope or meaning of the claims. In addition, in the Detailed Description, it can be seen that the description provides illustrative examples and the various features are grouped together in various embodiments for the purpose of streamlining the disclosure. This method of disclosure is not to be interpreted as reflecting an intention that the claimed subject matter requires more features than are expressly recited in any claim. Rather, as the following claims s reflect, inventive subject matter lies in less than all features of a single disclosed configuration or operation. The following claims are hereby incorporated into the Detailed Description, with each claims standing on its own to represent separately claimed subject matter.


The claims are not intended to be limited to the aspects described herein, but are to be accorded the full scope consistent with the language of the claims and to encompass all legal equivalents. Notwithstanding, none of the claims are intended to embrace subject matter that fails to satisfy the requirement of 35 U.S.C. § 101, 102, or 103, nor should they be interpreted in such a way.

Claims
  • 1. An aortic dissection system for treating a dissection within an aorta of a patient, the aortic dissection system comprising: an aortic dissection implant comprising: an expandable support structure having a proximal end and a distal end, the expandable support structure sized and configured to be positioned within an ascending portion of the aorta and sized and configured to extend to within a descending portion of the aorta and apply radial force to the descending portion of the aorta when expanded;at least one layer provided over the expandable support structure comprising an atraumatic outer surface configured to engage an inner wall of the aorta adjacent a false lumen associated with the dissection; andan expandable interface structure at the distal end of the expandable support structure having a cross-sectional dimension larger than a cross-section dimension of the expandable support structure when both are expanded, the expandable interface structure comprising a metallic frame having a trilobe shape comprising three lobes sized and configured to expand within a corresponding left coronary sinus, a right coronary sinus and a non-coronary sinus, respectively, wherein the trilobe shape is configured to extend from within the left and right coronary sinus distal of a left and right coronary ostia, respectively, and from within the non-coronary sinus, proximally to a sinotubular junction to apply radial force to the left, right and non-coronary sinuses and the sinotubular junction when the expandable interface structure is expanded; wherein the at least one layer extends over the expandable support structure and the expandable interface structure, and wherein the at least one layer comprises a porous section and a non-porous section; anda delivery system configured to be inserted percutaneously into the patient and advanced into the patient's aorta, the delivery system comprising an outer sheath configured to receive the aortic dissection implant therein in a compressed configuration.
  • 2. The system of claim 1, wherein the non-porous section is configured to extend across at least a portion of the dissection.
  • 3. The system of claim 1, wherein the porous section comprises a porous layer provided over the expandable support structure and the non-porous section comprises a non-porous layer provided over the porous layer.
  • 4. The system of claim 1, wherein the porous section is configured to permit blood flow from within the expandable support structure, through the porous section, and into the carotid arteries and the subclavian arteries.
  • 5. The system of claim 1, wherein the non-porous section comprises an opening to allow blood to flow from within the expandable support structure, through the opening, and into the carotid and the subclavian arteries.
  • 6. The system of claim 1, wherein the expandable support structure is pre-formed with a curvature to conform to the aortic arch.
  • 7. The system of claim 1, wherein the comprises a porous layer configured to substantially cover the expandable support structure from the descending aorta to the sinotubular junction and the non-porous section comprises a non-porous layer partially covering the porous layer and configured to engage a wall of the ascending aorta on opposite sides of a tear of the dissection.
  • 8. The system of claim 1, wherein the expandable interface structure comprises a wire frame.
  • 9. The system of claim 1, wherein the at least one layer is configured to extend within the left and right coronary sinuses without blocking blood flow into the left and right coronary arteries.
  • 10. The system of claim 1, wherein the non-porous section comprises a non-porous layer configured to be positioned across at least a portion of the dissection.
  • 11. The system of claim 1, wherein the at least one layer is configured to expand to engage the inner wall of the aorta separately from expansion of the expandable support structure, and the delivery system is configured to sequentially deploy the at least one layer before the expandable support structure.
  • 12. The system of claim 1, wherein the two lobes that are configured to extend within the left and right coronary sinuses are at least partially uncovered such that the left and right coronary ostia remain uncovered by the aortic dissection implant when in use.
  • 13. The system of claim 1, wherein each of the three lobes is sized and configured to conform to a curvature of the sinuses when the expandable interface structure is expanded.
  • 14. The system of claim 1, wherein each of the three lobes comprises a single apex at a distal end of the expandable anchoring structure configured to be positioned adjacent an aortic valve annulus of the patient.
  • 15. The system of claim 1, wherein the expandable support structure comprises a metallic frame that extends continuously from the proximal end to the distal end of the expandable support structure and that is continuous with the metallic frame of the expandable interface structure.
  • 16. The system of claim 15, wherein the expandable support structure and the expandable interface structure comprise separate frames.
  • 17. The system of claim 15, wherein the expandable support structure and the expandable interface structure are formed from a single continuous wire.
  • 18. An aortic dissection implant for treating a dissection within an aorta of a patient, the aortic dissection implant comprising: an expandable anchoring structure configured to be positioned within the aortic root of a patient and apply radial force to one or more of the sinuses of the aortic root and/or the sinotubular junction when expanded, wherein the expandable anchoring structure has a trilobe configuration comprising three lobes; andan elongate tubular structure having a proximal end configured to be positioned in the descending aorta and a distal end configured to be positioned in the ascending aorta, the sinotubular junction, or the aortic root, wherein the expandable anchoring structure is connected to or forms the distal end of the elongate tubular structure, wherein the elongate tubular structure comprises: an expandable support frame having a first length configured to extend from the descending aorta to at least the ascending aorta and curve along with a curvature of the aortic arch when expanded within the aorta, wherein the expandable support frame has a tubular shape when expanded and the expandable anchoring structure has a cross-sectional dimension larger than a cross-section dimension of the expandable support frame when expanded;a first porous layer positioned over the expandable support frame having a second length configured to extend from the descending aorta at least partially through the aortic arch, the first porous layer comprising an atraumatic outer surface and configured to allow blood to flow into the carotid and subclavian arteries;wherein expansion of the expandable support frame when positioned within the aorta expands the first porous layer such that the atraumatic outer surface of the first porous layer presses against an interior surface of the aorta and applies a radial force at least to the descending aorta; anda second non-porous layer positioned over the expandable support frame having a third length that is less than the first length, wherein the second non-porous layer is configured to be positioned within the ascending aorta and distal to the carotid and subclavian arteries in use, wherein the second layer is configured to be positioned against a length of a tear of the dissection.
  • 19. The aortic dissection implant of claim 18, wherein the second length of the first porous layer is approximately the same as the first length of the expandable support frame.
  • 20. The aortic dissection implant of claim 18, wherein one or both of the first porous layer and the second non-porous layer comprises a fabric material.
  • 21. The aortic dissection implant of claim 18, wherein the expandable support frame comprises a wire, a coiled ribbon, a laser cut structure, or a braid.
  • 22. The aortic dissection implant of claim 18, wherein the atraumatic outer surface of the first porous layer is configured to engage an interior surface of the aorta within the aortic arch and to allow blood flow from the aortic arch, through the first porous layer, and to the carotid and/or subclavian arteries.
  • 23. The aortic dissection implant of claim 18, wherein the expandable anchoring structure comprises openings for allowing blood flow to the left and right coronary ostia.
  • 24. The aortic dissection implant of claim 18, wherein the second non-porous layer is configured to be positioned over the expandable support frame within the ascending aorta.
  • 25. The aortic dissection implant of claim 18, wherein the second non-porous layer is configured to extend from within the aortic root to within the ascending aorta in use.
  • 26. The aortic dissection implant of claim 18, wherein the three lobes are sized and configured to extend from a location distal of a left and a right coronary ostia proximally to a sinotubular junction to apply radial force to the sinuses and the sinotubular junction when the expandable anchoring structure is expanded.
  • 27. The aortic dissection implant of claim 18, wherein each of the three lobes is sized and configured to conform to a curvature of the sinuses when the expandable anchoring structure is expanded.
  • 28. The aortic dissection implant of claim 18, wherein the expandable anchoring structure and the elongate tubular structure comprise a continuous metallic frame extending from the proximal end of the elongate tubular structure to the trilobe configuration of the expandable anchoring structure.
INCORPORATION BY REFERENCE TO ANY PRIORITY APPLICATIONS

This application claims the benefit of U.S. Provisional Application No. 62/821,052, filed Mar. 20, 2019, the entirety of which is hereby incorporated by reference.

US Referenced Citations (546)
Number Name Date Kind
4313231 Koyamada Feb 1982 A
4577631 Kreamer Mar 1986 A
4820298 Leveen et al. Apr 1989 A
4994071 MacGregor Feb 1991 A
5102417 Palmaz Apr 1992 A
5133732 Wiktor Jul 1992 A
5195984 Schatz Mar 1993 A
5207695 Trout, III Apr 1993 A
5211658 Clouse May 1993 A
5316023 Palmaz et al. May 1994 A
5360443 Barone et al. Nov 1994 A
5387235 Chuter Feb 1995 A
5464449 Ryan et al. Nov 1995 A
5489295 Piplani et al. Feb 1996 A
5507769 Marin et al. Apr 1996 A
5507770 Turk Apr 1996 A
5562724 Vorwerk et al. Oct 1996 A
5578071 Parodi Nov 1996 A
5591195 Taheri et al. Jan 1997 A
5591230 Taheri et al. Jan 1997 A
5665117 Rhodes Sep 1997 A
5676697 McDonald Oct 1997 A
5683449 Marcade Nov 1997 A
5683450 Goicoechea et al. Nov 1997 A
5733325 Robinson et al. Mar 1998 A
5741325 Chaikof et al. Apr 1998 A
5755773 Evans et al. May 1998 A
5776185 Verona et al. Jul 1998 A
5782904 White et al. Jul 1998 A
5782905 Richter Jul 1998 A
5824040 Cox et al. Oct 1998 A
5824041 Lenker et al. Oct 1998 A
5827321 Roubin et al. Oct 1998 A
5843164 Frantzen et al. Dec 1998 A
5861025 Boudghene et al. Jan 1999 A
5871537 Holman et al. Feb 1999 A
5906641 Thompson et al. May 1999 A
5925076 Inoue Jul 1999 A
5968090 Ratcliff et al. Oct 1999 A
6015431 Thornton et al. Jan 2000 A
6016810 Ravenscroft Jan 2000 A
6051020 Goicoechea et al. Apr 2000 A
6051021 Frid Apr 2000 A
6077296 Shokoohi et al. Jun 2000 A
6096072 Kanesaka et al. Aug 2000 A
6098630 Papazoglou Aug 2000 A
6099548 Taheri Aug 2000 A
6099558 White et al. Aug 2000 A
6102940 Robichon et al. Aug 2000 A
6106549 Taheri Aug 2000 A
6113621 Wiktor Sep 2000 A
6123723 Kónya et al. Sep 2000 A
6129755 Mathis et al. Oct 2000 A
6129756 Kugler et al. Oct 2000 A
6143022 Shull et al. Nov 2000 A
6149682 Frid Nov 2000 A
6162246 Barone Dec 2000 A
6168610 Marin et al. Jan 2001 B1
6190406 Duerig et al. Feb 2001 B1
6203568 Lombardi et al. Mar 2001 B1
6214036 Letendre et al. Apr 2001 B1
6221096 Aiba et al. Apr 2001 B1
6224609 Ressemann et al. May 2001 B1
6261305 Marotta et al. Jul 2001 B1
6273909 Kugler et al. Aug 2001 B1
6280466 Kugler et al. Aug 2001 B1
6290731 Solovay et al. Sep 2001 B1
6306164 Kujawski Oct 2001 B1
6312462 McDermott et al. Nov 2001 B1
6325819 Pavcnik et al. Dec 2001 B1
6334869 Leonhardt et al. Jan 2002 B1
6348066 Pinchuk et al. Feb 2002 B1
6352561 Leopold et al. Mar 2002 B1
6375676 Cox Apr 2002 B1
6395018 Castaneda May 2002 B1
6402779 Colone et al. Jun 2002 B1
6409750 Hyodoh et al. Jun 2002 B1
6478813 Keith et al. Nov 2002 B1
6491719 Fogarty et al. Dec 2002 B1
6500202 Shaolian et al. Dec 2002 B1
6508835 Shaolian et al. Jan 2003 B1
6554858 Dereume et al. Apr 2003 B2
6569190 Whalen, II et al. May 2003 B2
6585758 Chouinard et al. Jul 2003 B1
6592614 Lenker et al. Jul 2003 B2
6613078 Barone Sep 2003 B1
6626938 Butaric et al. Sep 2003 B1
6656214 Fogarty et al. Dec 2003 B1
6656219 Wiktor Dec 2003 B1
6695876 Marotta et al. Feb 2004 B1
6699277 Freidberg et al. Mar 2004 B1
6723116 Taheri Apr 2004 B2
6770090 Gantt et al. Aug 2004 B2
6773454 Wholey et al. Aug 2004 B2
6773457 Ivancev et al. Aug 2004 B2
6793671 Wall Sep 2004 B2
6814752 Chuter Nov 2004 B1
6827735 Greenberg Dec 2004 B2
6881221 Golds Apr 2005 B2
6887268 Butaric et al. May 2005 B2
6916337 Roth Jul 2005 B2
6918925 Tehrani Jul 2005 B2
6923828 Wiktor Aug 2005 B1
6945991 Brodeur et al. Sep 2005 B1
6951572 Douglas Oct 2005 B1
6960217 Bolduc Nov 2005 B2
6964679 Marcade et al. Nov 2005 B1
6969401 Marotta et al. Nov 2005 B1
6974471 Van Schie et al. Dec 2005 B2
7000649 Takahashi et al. Feb 2006 B2
7011674 Brenneman Mar 2006 B2
7014653 Ouriel et al. Mar 2006 B2
7025778 Hayashi et al. Apr 2006 B2
7029496 Rakos et al. Apr 2006 B2
7033389 Sherry Apr 2006 B2
7074235 Roy Jul 2006 B1
7105017 Kerr Sep 2006 B2
7105020 Greenberg et al. Sep 2006 B2
7147660 Chobotov et al. Dec 2006 B2
7160318 Greenberg et al. Jan 2007 B2
7175652 Cook et al. Feb 2007 B2
7175657 Khan et al. Feb 2007 B2
7192441 Sherry Mar 2007 B2
7201769 Jones et al. Apr 2007 B2
7229472 DePalma et al. Jun 2007 B2
7261733 Brown et al. Aug 2007 B1
7267685 Butaric et al. Sep 2007 B2
7273491 Fischell et al. Sep 2007 B2
7294147 Hartley Nov 2007 B2
7314483 Landau et al. Jan 2008 B2
7318835 Berra Jan 2008 B2
7320703 DiMatteo et al. Jan 2008 B2
7326237 DePalma et al. Feb 2008 B2
7344562 Feller et al. Mar 2008 B2
7347869 Hojeibane et al. Mar 2008 B2
7393357 Stelter et al. Jul 2008 B2
7407509 Greenberg et al. Aug 2008 B2
7410665 Ragheb et al. Aug 2008 B2
7435253 Hartley et al. Oct 2008 B1
7438721 Doig et al. Oct 2008 B2
7488344 Hartley et al. Feb 2009 B2
7520895 Douglas et al. Apr 2009 B2
7530988 Evans et al. May 2009 B2
7537606 Hartley et al. May 2009 B2
7575590 Watson Aug 2009 B2
7588596 Spiridigliozzi et al. Sep 2009 B2
7588597 Frid Sep 2009 B2
7632304 Park Dec 2009 B2
7655036 Goodson Feb 2010 B2
7655037 Fleming, III et al. Feb 2010 B2
7666220 Evans et al. Feb 2010 B2
7670369 Schaeffer Mar 2010 B2
7678141 Greenan et al. Mar 2010 B2
7682380 Thornton et al. Mar 2010 B2
7682383 Robin Mar 2010 B2
7686842 Pavcnik et al. Mar 2010 B2
7699883 Douglas Apr 2010 B2
7699885 Leonhardt et al. Apr 2010 B2
7708773 Pinchuk et al. May 2010 B2
7758634 Brucker et al. Jul 2010 B2
7763062 Spiridigliozzi et al. Jul 2010 B2
7780718 Smith Aug 2010 B2
7785365 Holman et al. Aug 2010 B2
7789903 Spiridigliozzi et al. Sep 2010 B2
7806917 Xiao Oct 2010 B2
7828839 Cook et al. Nov 2010 B2
7833259 Boatman Nov 2010 B2
7892277 Douglas et al. Feb 2011 B2
7912554 Capuano et al. Mar 2011 B2
7918800 Brown et al. Apr 2011 B1
7955372 Butterwick et al. Jun 2011 B2
7959662 Erbel et al. Jun 2011 B2
7993383 Hartley et al. Aug 2011 B2
7993386 Elliott Aug 2011 B2
8002816 Greenberg Aug 2011 B2
8021408 Kang et al. Sep 2011 B2
8021413 Dierking et al. Sep 2011 B2
8048140 Purdy Nov 2011 B2
8048147 Adams Nov 2011 B2
8052741 Bruszewski et al. Nov 2011 B2
8062345 Ouellette et al. Nov 2011 B2
8062346 Quigley et al. Nov 2011 B2
8066755 Zacharias et al. Nov 2011 B2
8088156 Borges et al. Jan 2012 B2
8118862 Saeed Feb 2012 B2
8123796 Kasprzak Feb 2012 B2
8163006 Feller et al. Apr 2012 B2
8167925 Shaolian et al. May 2012 B2
8167930 Allen et al. May 2012 B2
8187317 Leprince et al. May 2012 B2
8202310 Majercak et al. Jun 2012 B2
8211158 Wolf Jul 2012 B2
8226708 Murch Jul 2012 B1
8236040 Mayberry et al. Aug 2012 B2
8252036 Cartledge et al. Aug 2012 B2
8252039 Golesworthy et al. Aug 2012 B2
8257423 Kerr Sep 2012 B2
8257430 Mead Sep 2012 B2
8262692 Rudakov Sep 2012 B2
8287586 Schaeffer et al. Oct 2012 B2
8292949 Berra et al. Oct 2012 B2
8293261 Nagura Oct 2012 B2
8298281 Majercak et al. Oct 2012 B2
8333800 Bruszewski et al. Dec 2012 B2
8337546 Bruszewski Dec 2012 B2
8353943 Kuppurathanam et al. Jan 2013 B2
8377110 Douglas et al. Feb 2013 B2
8377113 Hartley et al. Feb 2013 B2
8388679 Du Mar 2013 B2
8398703 Kassab et al. Mar 2013 B2
8474120 Hagaman et al. Jul 2013 B2
8480725 Rasmussen et al. Jul 2013 B2
8486131 Shalev Jul 2013 B2
8491649 Mach Jul 2013 B2
8500792 Berra Aug 2013 B2
8506622 Bruszewski et al. Aug 2013 B2
8518096 Nelson Aug 2013 B2
8523931 Mayberry et al. Sep 2013 B2
8540764 Bruszewski et al. Sep 2013 B2
8545549 Hartley et al. Oct 2013 B2
8551157 Hamer et al. Oct 2013 B2
8551158 Roeder et al. Oct 2013 B2
8562667 Cox Oct 2013 B2
8574284 Roeder et al. Nov 2013 B2
8585753 Scanlon et al. Nov 2013 B2
8603153 Haverkost Dec 2013 B2
8632581 Chuter Jan 2014 B2
8652195 Tani Feb 2014 B2
8663307 Arbefeuille Mar 2014 B2
8663310 Greenberg et al. Mar 2014 B2
8663315 Hong et al. Mar 2014 B2
8668729 Kaufmann et al. Mar 2014 B2
8679171 Deem et al. Mar 2014 B2
8702785 Khan et al. Apr 2014 B2
8715340 Rudakov et al. May 2014 B2
8728144 Fearnot May 2014 B2
8728145 Chuter et al. May 2014 B2
8728148 Roeder et al. May 2014 B2
8734501 Hartley et al. May 2014 B2
8740963 Arbefeuille et al. Jun 2014 B2
8740971 Iannelli Jun 2014 B2
8747453 Amplatz et al. Jun 2014 B2
8747455 Greenberg Jun 2014 B2
8753386 Shaw Jun 2014 B2
8778008 Amplatz et al. Jul 2014 B2
8845676 Monstadt et al. Sep 2014 B2
8845714 DiMatteo et al. Sep 2014 B2
8858613 Cragg et al. Oct 2014 B2
8864813 Barr Oct 2014 B2
8870938 Shalev et al. Oct 2014 B2
8876886 Kaufmann et al. Nov 2014 B2
8900287 Amplatz et al. Dec 2014 B2
8906081 Cully et al. Dec 2014 B2
8911468 Ogle et al. Dec 2014 B2
8911491 Hanson et al. Dec 2014 B2
8915955 West et al. Dec 2014 B2
8915956 Schaeffer et al. Dec 2014 B2
8926682 Herbowy et al. Jan 2015 B2
8926688 Burkart et al. Jan 2015 B2
8945199 Ganpath et al. Feb 2015 B2
8945202 Mayberry et al. Feb 2015 B2
8945205 Greenberg Feb 2015 B2
8945207 Mattsson et al. Feb 2015 B2
8951298 Shalev Feb 2015 B2
8961587 Zhu et al. Feb 2015 B2
8968384 Pears0n et al. Mar 2015 B2
8974518 Bruszewski et al. Mar 2015 B2
8992592 Molaei et al. Mar 2015 B2
9005268 Hartley et al. Apr 2015 B2
9005270 Perkins et al. Apr 2015 B2
9005271 Ivancev et al. Apr 2015 B2
9011517 Hartley et al. Apr 2015 B2
9028541 Abunassar May 2015 B2
9034027 Ivancev May 2015 B2
9044311 Rasmussen et al. Jun 2015 B2
9055999 Thomas et al. Jun 2015 B2
9056000 Luo et al. Jun 2015 B2
9066824 Madjarov Jun 2015 B2
9095421 Peterson Aug 2015 B2
9095456 Ivancev et al. Aug 2015 B2
9101506 Arbefeuille et al. Aug 2015 B2
9113999 Taylor et al. Aug 2015 B2
9125764 Shaw Sep 2015 B2
9138228 Vassiliades et al. Sep 2015 B2
9149373 Davis et al. Oct 2015 B2
9149382 Greenberg et al. Oct 2015 B2
9155641 Schaeffer et al. Oct 2015 B2
9168162 Smouse Oct 2015 B2
9175427 Haselby et al. Nov 2015 B2
9179998 Kölbel et al. Nov 2015 B2
9186267 Losordo et al. Nov 2015 B2
9211183 Ivancev et al. Dec 2015 B2
9226813 Brocker et al. Jan 2016 B2
9265599 Greenberg et al. Feb 2016 B2
9308079 Koskas et al. Apr 2016 B2
9314327 Orr Apr 2016 B2
9314353 Heraty et al. Apr 2016 B2
9345594 Woerne May 2016 B2
9351822 Roeder May 2016 B2
9393100 Schreck Jul 2016 B2
9393136 Perkins et al. Jul 2016 B2
9402712 Cam et al. Aug 2016 B2
9402754 Chan et al. Aug 2016 B2
9408607 Cartledge et al. Aug 2016 B2
9408731 Hartley et al. Aug 2016 B2
9427306 Shahriari Aug 2016 B2
9427339 Shalev Aug 2016 B2
9439758 Keeble et al. Sep 2016 B2
9463102 Kelly Oct 2016 B2
9463105 Farhat et al. Oct 2016 B2
9486341 Shalev Nov 2016 B2
9498322 Thomas Nov 2016 B2
9498361 Roeder et al. Nov 2016 B2
9526642 Arnault De La Menardiere et al. Dec 2016 B2
9526813 Cohn et al. Dec 2016 B2
9545323 Cully Jan 2017 B2
9561121 Sudin et al. Feb 2017 B2
9572652 Cragg et al. Feb 2017 B2
9579103 Schreck Feb 2017 B2
9585668 Rudakov et al. Mar 2017 B2
9585743 Cartledge et al. Mar 2017 B2
9597204 Benary et al. Mar 2017 B2
9603697 Centola Mar 2017 B2
9655710 Eller et al. May 2017 B2
9662196 Roeder et al. May 2017 B2
9668892 Shalev et al. Jun 2017 B2
9687366 Golden Jun 2017 B2
9717611 Jensen et al. Aug 2017 B2
9724187 Ivancev et al. Aug 2017 B2
9737394 Coghlan et al. Aug 2017 B2
9757260 Greenan Sep 2017 B2
9757262 Schreck Sep 2017 B2
9757263 Roeder et al. Sep 2017 B2
9763813 Park Sep 2017 B2
9763816 Roeder Sep 2017 B2
9770320 Eells et al. Sep 2017 B2
9788933 Sun et al. Oct 2017 B2
9788934 Chobotov et al. Oct 2017 B2
9820875 Laduca Nov 2017 B2
9833341 Bogenschuetz et al. Dec 2017 B2
9839542 Bruszewski et al. Dec 2017 B2
9848869 Bolduc et al. Dec 2017 B2
9848976 Angel et al. Dec 2017 B2
9849006 Kozyak et al. Dec 2017 B2
9855128 Kölbel et al. Jan 2018 B2
9861466 Havel et al. Jan 2018 B2
9877857 Arbefeuille et al. Jan 2018 B2
9907642 Schreck et al. Mar 2018 B2
9907681 Tobis et al. Mar 2018 B2
9907683 Zukowski et al. Mar 2018 B2
9907684 Connor et al. Mar 2018 B2
9918861 Huser et al. Mar 2018 B2
9925031 Macatangay Mar 2018 B2
9925032 Jensen et al. Mar 2018 B2
9943427 Losordo et al. Apr 2018 B2
9949692 Hunter Apr 2018 B2
9949818 Kelly Apr 2018 B2
9955971 Xu et al. May 2018 B2
9968353 Bolduc et al. May 2018 B2
9974671 Bolduc et al. May 2018 B2
9993328 Young et al. Jun 2018 B2
9993329 McDonald et al. Jun 2018 B2
9993330 Roeder Jun 2018 B2
9993360 Shalev et al. Jun 2018 B2
10010402 Wang et al. Jul 2018 B2
10010403 Marrocco et al. Jul 2018 B2
10022249 Evans et al. Jul 2018 B2
10028848 Shahriari Jul 2018 B2
10028849 Bui et al. Jul 2018 B2
10029424 Verschueren et al. Jul 2018 B2
10034785 Schonholz et al. Jul 2018 B1
10034788 Kasprzak, II et al. Jul 2018 B2
10039655 Pung et al. Aug 2018 B2
10070950 Piccagli et al. Sep 2018 B2
10098770 Bolduc et al. Oct 2018 B2
10105209 Kerr Oct 2018 B2
10105248 Berra et al. Oct 2018 B2
10137013 Giasolli et al. Nov 2018 B2
10143576 Greenberg et al. Dec 2018 B2
10154894 Minion Dec 2018 B2
10159557 Chobotov et al. Dec 2018 B2
10188501 Wang et al. Jan 2019 B2
10201413 Shalev et al. Feb 2019 B2
10206798 Kusleika Feb 2019 B2
10213291 Berra et al. Feb 2019 B2
10219890 Madjarov et al. Mar 2019 B2
10226366 Wainwright et al. Mar 2019 B2
10231822 Hartley Mar 2019 B2
10231857 Tal Mar 2019 B2
10245166 Schreck et al. Apr 2019 B2
10265200 Charlebois et al. Apr 2019 B2
10265202 Greenberg et al. Apr 2019 B2
10271941 Wintsch et al. Apr 2019 B2
10278840 Tippett et al. May 2019 B2
10292808 Mangiardi May 2019 B2
10292809 Kuppurathanam et al. May 2019 B2
10299946 Roselli May 2019 B2
10307244 Ganesan et al. Jun 2019 B2
10321985 Barthold et al. Jun 2019 B2
10327782 Horton Jun 2019 B2
10327924 Kelly Jun 2019 B2
10335297 Vong et al. Jul 2019 B2
10349946 Herbowy et al. Jul 2019 B2
10357353 Kelly Jul 2019 B2
10357386 Schaeffer et al. Jul 2019 B2
10368977 Eller et al. Aug 2019 B2
10383752 Shahriari et al. Aug 2019 B2
10390930 Arbefeuille et al. Aug 2019 B2
10390932 Lostetter Aug 2019 B2
10405964 Hannes et al. Sep 2019 B2
10405965 Kelly Sep 2019 B2
10405966 Johnson Sep 2019 B2
10420637 Fierens et al. Sep 2019 B2
10441221 Spindler Oct 2019 B2
10463517 Bradway et al. Nov 2019 B2
10470868 Kim et al. Nov 2019 B2
10470870 Schreck et al. Nov 2019 B2
10478195 Aboytes et al. Nov 2019 B2
10478320 Shahriari Nov 2019 B2
10485649 Barthold et al. Nov 2019 B2
10485684 Marmur et al. Nov 2019 B2
10492900 Kelly Dec 2019 B2
20010014794 Moll et al. Aug 2001 A1
20010018609 Smith Aug 2001 A1
20010037137 Vardi et al. Nov 2001 A1
20010049554 Ruiz et al. Dec 2001 A1
20020115982 Barbut Aug 2002 A1
20020183628 Reich et al. Dec 2002 A1
20030104030 Igaki et al. Jun 2003 A1
20030139802 Wulfman et al. Jul 2003 A1
20030139803 Sequin et al. Jul 2003 A1
20030149472 Pinchuk et al. Aug 2003 A1
20030195617 Schatz Oct 2003 A1
20030225453 Murch Dec 2003 A1
20040093068 Bergen et al. May 2004 A1
20040093078 Moll et al. May 2004 A1
20040098091 Erbel et al. May 2004 A1
20040116998 Erbel et al. Jun 2004 A1
20040215335 Brin et al. Oct 2004 A1
20040230295 Shaolian et al. Nov 2004 A1
20050021133 Li Jan 2005 A1
20050033405 Solovay Feb 2005 A1
20050266043 Tseng et al. Dec 2005 A1
20060030911 Letort Feb 2006 A1
20060106406 Weinberger May 2006 A1
20060161241 Barbut et al. Jul 2006 A1
20060206198 Churchwell et al. Sep 2006 A1
20060212113 Shaolian et al. Sep 2006 A1
20060253190 Kuo Nov 2006 A1
20060271163 Shokoohi et al. Nov 2006 A1
20060271164 Shaolian et al. Nov 2006 A1
20060009835 Osborne et al. Dec 2006 A1
20060276883 Greenberg et al. Dec 2006 A1
20070038288 Lye et al. Feb 2007 A1
20070118208 Kerr May 2007 A1
20070156228 Majercak et al. Jul 2007 A1
20070168013 Douglas Jul 2007 A1
20070173921 Wholey et al. Jul 2007 A1
20070208410 Berra et al. Sep 2007 A1
20070282422 Biggs et al. Dec 2007 A1
20070299497 Shaolian et al. Dec 2007 A1
20080082154 Tseng et al. Apr 2008 A1
20080097578 Erickson et al. Apr 2008 A1
20080109055 Hlavka et al. May 2008 A1
20080208312 Kwitkin et al. Aug 2008 A1
20080208317 Jang et al. Aug 2008 A1
20080262604 Stengel Oct 2008 A1
20090030502 Sun et al. Jan 2009 A1
20090093873 Navia Apr 2009 A1
20090099652 Granada et al. Apr 2009 A1
20090164001 Biggs et al. Jun 2009 A1
20090264993 Greenan Oct 2009 A1
20090270965 Sinha et al. Oct 2009 A1
20100087907 Lattouf Apr 2010 A1
20100174357 LeMaitre et al. Jul 2010 A1
20100241163 Wilcox et al. Sep 2010 A1
20100249898 Gale et al. Sep 2010 A1
20100256728 Rea Peterson Oct 2010 A1
20100318174 Shaolian et al. Dec 2010 A1
20110022153 Schreck Jan 2011 A1
20110190867 VonderWalde et al. Aug 2011 A1
20110196477 Ganesan Aug 2011 A1
20110218608 Cheng et al. Sep 2011 A1
20110270379 Bruszewski Nov 2011 A1
20120116500 Jang et al. May 2012 A1
20120191174 Vinluan et al. Jul 2012 A1
20120316632 Gao Dec 2012 A1
20130066416 Goicoechea et al. Mar 2013 A1
20130166015 Roeder Jun 2013 A1
20130204351 Cox et al. Aug 2013 A1
20130310922 Stengel Nov 2013 A1
20140018902 Myr Jan 2014 A1
20140243952 Parodi Aug 2014 A1
20140336745 Barthold et al. Nov 2014 A1
20150012081 Robin Jan 2015 A1
20150190255 Molaei et al. Jul 2015 A1
20160030155 Cox et al. Feb 2016 A1
20160067071 Jose et al. Mar 2016 A1
20160184076 Choubey et al. Jun 2016 A1
20160184077 Choubey et al. Jun 2016 A1
20160184078 Choubey et al. Jun 2016 A1
20160338823 Akingba Nov 2016 A1
20160361153 Shahriari Dec 2016 A1
20170007392 Lourenco et al. Jan 2017 A1
20170135806 Ombrellaro May 2017 A1
20170216062 Armstrong et al. Aug 2017 A1
20170296326 Chua et al. Oct 2017 A1
20170319359 Mehta Nov 2017 A1
20170333046 Roselli Nov 2017 A1
20180036111 Despalle De Bearn Feb 2018 A1
20180098837 Shahriari Apr 2018 A1
20180125636 Kerr May 2018 A1
20180206972 Arbefeuille et al. Jul 2018 A1
20180221130 Schreck Aug 2018 A1
20180243113 Walzman Aug 2018 A1
20180256189 Roeder et al. Sep 2018 A1
20180256190 Roeder et al. Sep 2018 A1
20180303598 Szopinski Oct 2018 A1
20190029798 Walther et al. Jan 2019 A1
20190069986 Lukas Mar 2019 A1
20190070026 Fulton Mar 2019 A1
20190070027 Wang et al. Mar 2019 A1
20190083227 Barone Mar 2019 A1
20190105149 Roselli et al. Apr 2019 A1
20190105150 Tsao Apr 2019 A1
20190110912 Liebig et al. Apr 2019 A1
20190133749 Liu May 2019 A1
20190159886 Lourenco May 2019 A1
20190209285 Gibbons, Jr. et al. Jul 2019 A1
20190231358 Henkes et al. Aug 2019 A1
20190231513 Leuthardt et al. Aug 2019 A1
20190239895 Dawson et al. Aug 2019 A1
20190240049 Dawson et al. Aug 2019 A1
20190240050 Dawson et al. Aug 2019 A1
20190247051 Siddiqui Aug 2019 A1
20190247179 Lostetter Aug 2019 A1
20190254817 Centola et al. Aug 2019 A1
20190269497 Arbefeuille Sep 2019 A1
20190282355 Lostetter Sep 2019 A1
20190314138 O'Brien et al. Oct 2019 A1
20190343533 Costalat Nov 2019 A1
20190365523 Haulon et al. Dec 2019 A1
20190365524 Wilger et al. Dec 2019 A1
20190365525 Bradway et al. Dec 2019 A1
20190374232 Lorenzo Dec 2019 A1
20190380825 Perkins et al. Dec 2019 A1
Foreign Referenced Citations (217)
Number Date Country
2007201644 May 2007 AU
0335341 Oct 1989 EP
0806191 Nov 1997 EP
0621016 Aug 1999 EP
0579523 Sep 2001 EP
1214021 Jun 2002 EP
0766539 May 2003 EP
1312320 May 2003 EP
0836449 Aug 2003 EP
1356788 Oct 2003 EP
1364626 Nov 2003 EP
0699424 Mar 2004 EP
0969778 Sep 2004 EP
0747020 Jan 2005 EP
0955954 Mar 2005 EP
1523999 Apr 2005 EP
1534177 Jun 2005 EP
0861638 Sep 2005 EP
1107708 Jan 2006 EP
1616585 Jan 2006 EP
1263348 Feb 2006 EP
0955017 Jun 2006 EP
1135082 Aug 2006 EP
1749545 Feb 2007 EP
1772115 Apr 2007 EP
1307162 Feb 2008 EP
1487380 Feb 2008 EP
1788977 Mar 2008 EP
1920734 May 2008 EP
1955680 Aug 2008 EP
1961401 Aug 2008 EP
1803418 Oct 2008 EP
1673037 Aug 2009 EP
1333787 Dec 2009 EP
1311208 Mar 2010 EP
2030592 May 2010 EP
1338252 Jul 2010 EP
2063812 Nov 2010 EP
1933763 Jan 2011 EP
1924220 Aug 2011 EP
2224880 Jan 2013 EP
2550943 Jan 2013 EP
2387379 Mar 2013 EP
1503701 Aug 2013 EP
1985258 Nov 2013 EP
2679197 Jan 2014 EP
2698126 Feb 2014 EP
2708208 Mar 2014 EP
2769701 Aug 2014 EP
1123063 Mar 2015 EP
2915509 Sep 2015 EP
2654629 Oct 2015 EP
2499997 Nov 2015 EP
2590602 Dec 2015 EP
1962722 Mar 2016 EP
2328512 Apr 2016 EP
2777609 Jun 2016 EP
2403439 Jul 2016 EP
2846733 Aug 2016 EP
2706954 Oct 2016 EP
3085339 Oct 2016 EP
3090707 Nov 2016 EP
2775958 Jan 2017 EP
2298248 Apr 2017 EP
3284439 Feb 2018 EP
3315092 May 2018 EP
3326582 May 2018 EP
2846731 Jul 2018 EP
2999429 Jul 2018 EP
3003230 Jul 2018 EP
3351210 Jul 2018 EP
2543345 Aug 2018 EP
2967577 Aug 2018 EP
3391852 Oct 2018 EP
3395295 Oct 2018 EP
3395302 Oct 2018 EP
3395300 Nov 2018 EP
3421010 Jan 2019 EP
3431038 Jan 2019 EP
3431039 Jan 2019 EP
3443935 Feb 2019 EP
3248572 May 2019 EP
3197394 Jul 2019 EP
3524175 Aug 2019 EP
3539507 Sep 2019 EP
3244828 Dec 2019 EP
3253330 Dec 2019 EP
3578134 Dec 2019 EP
3578135 Dec 2019 EP
3578136 Dec 2019 EP
2806826 Jan 2020 EP
3060177 Jan 2020 EP
3397202 Jan 2020 EP
3323385 Mar 2020 EP
3448312 Mar 2020 EP
2811937 Apr 2020 EP
3448313 Apr 2020 EP
WO 9503754 Feb 1995 WO
WO 9815237 Apr 1998 WO
WO 9822045 May 1998 WO
WO 9841167 Sep 1998 WO
WO 9951165 Oct 1999 WO
WO 0121108 Mar 2001 WO
WO 0139696 Jun 2001 WO
WO 0193782 Dec 2001 WO
WO 0200139 Jan 2002 WO
WO 0222049 Mar 2002 WO
WO 0243799 Jun 2002 WO
WO 02087473 Nov 2002 WO
WO 03007785 Jan 2003 WO
WO 03039613 May 2003 WO
WO 03086239 Oct 2003 WO
WO 03099108 Dec 2003 WO
WO 2004037116 May 2004 WO
WO 2004045452 Jun 2004 WO
WO 2004096090 Nov 2004 WO
WO 2005086942 Sep 2005 WO
WO 2005102221 Nov 2005 WO
WO 2005112823 Dec 2005 WO
WO 2005122957 Dec 2005 WO
WO 2006047184 May 2006 WO
WO 2006067534 Jun 2006 WO
WO 2006071487 Jul 2006 WO
WO 2006072835 Jul 2006 WO
WO 2006072934 Jul 2006 WO
WO 2006091891 Aug 2006 WO
WO 2006103641 Oct 2006 WO
WO 2007028112 Mar 2007 WO
WO 2007080352 Jul 2007 WO
WO 2007088549 Aug 2007 WO
WO 2007112025 Oct 2007 WO
WO 2008072838 Jun 2008 WO
WO 2008091925 Jul 2008 WO
WO 2008157507 Dec 2008 WO
WO 2009019664 Feb 2009 WO
WO 2009104000 Aug 2009 WO
WO 2009140638 Nov 2009 WO
WO 2009158170 Dec 2009 WO
WO 2010027363 Mar 2010 WO
WO 2010027677 Mar 2010 WO
WO 2010054604 May 2010 WO
WO 2010083558 Jul 2010 WO
WO 2010111666 Sep 2010 WO
WO 2010120417 Oct 2010 WO
WO 2011007354 Jan 2011 WO
WO 2011023105 Mar 2011 WO
WO 2011110092 Sep 2011 WO
WO 2012016886 Feb 2012 WO
WO 2012061526 May 2012 WO
WO 2012145826 Nov 2012 WO
WO 2012153069 Nov 2012 WO
WO 2012159524 Nov 2012 WO
WO 2013016984 Feb 2013 WO
WO 2013030819 Mar 2013 WO
WO 2013097759 Jul 2013 WO
WO 2013116860 Aug 2013 WO
WO 2013162682 Oct 2013 WO
WO 2014028913 Feb 2014 WO
WO 2014072501 May 2014 WO
WO 2014169267 Oct 2014 WO
WO 2014180161 Nov 2014 WO
WO 2016044647 Mar 2016 WO
WO 2016065208 Apr 2016 WO
WO 2016075615 May 2016 WO
WO 2016109753 Jul 2016 WO
WO 2016109757 Jul 2016 WO
WO 2016122862 Aug 2016 WO
WO 2016123676 Aug 2016 WO
WO 2016125137 Aug 2016 WO
WO 2016191602 Dec 2016 WO
WO 2016203040 Dec 2016 WO
WO 2016205826 Dec 2016 WO
WO 2017040659 Mar 2017 WO
WO 2017081213 May 2017 WO
WO 2017105479 Jun 2017 WO
WO 2017134198 Aug 2017 WO
WO 2017165840 Sep 2017 WO
WO 2017172735 Oct 2017 WO
WO 2017205486 Nov 2017 WO
WO 2017191511 Nov 2017 WO
WO 2017207689 Dec 2017 WO
WO 2017220400 Dec 2017 WO
WO 2018007230 Jan 2018 WO
WO 2018026768 Feb 2018 WO
WO 2018035167 Feb 2018 WO
WO 2018045097 Mar 2018 WO
WO 2018046917 Mar 2018 WO
WO 2018052878 Mar 2018 WO
WO 2018060716 Apr 2018 WO
WO 2018067171 Apr 2018 WO
WO 2018077499 May 2018 WO
WO 2018077821 May 2018 WO
WO 2018091464 May 2018 WO
WO 2018095090 May 2018 WO
WO 2018106573 Jun 2018 WO
WO 2018163056 Sep 2018 WO
WO 2018173056 Sep 2018 WO
WO 2018200972 Nov 2018 WO
WO 2019010458 Jan 2019 WO
WO 2019012123 Jan 2019 WO
WO 2019048551 Mar 2019 WO
WO 2019059949 Mar 2019 WO
WO 2019072912 Apr 2019 WO
WO 2019084951 May 2019 WO
WO 2019085981 May 2019 WO
WO 2019097328 May 2019 WO
WO 2019101077 May 2019 WO
WO 2019101078 May 2019 WO
WO 2019101079 May 2019 WO
WO 2019122665 Jun 2019 WO
WO 2019122944 Jun 2019 WO
WO 2019126060 Jun 2019 WO
WO 2019128775 Jul 2019 WO
WO 2019144870 Aug 2019 WO
WO 2019174991 Sep 2019 WO
WO 2019188345 Oct 2019 WO
WO 2019205599 Oct 2019 WO
Non-Patent Literature Citations (1)
Entry
International Search Report and Written Opinion in PCT/US2020/023651, dated Jun. 17, 2020, in 17 pages.
Related Publications (1)
Number Date Country
20200297475 A1 Sep 2020 US
Provisional Applications (1)
Number Date Country
62821052 Mar 2019 US